Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1050.Time spend outdoors in summer,47028,0.0395992450605009,0.0382555430329432,-0.0353816192840678,0.11458010940507,0.300624414543828
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1060.Time spent outdoors in winter,45177,0.0547795973696635,0.0423358463025567,-0.0281986613833476,0.137757856122675,0.195707826679426
CCND2,G1/S-specific cyclin-D2,Physical activities,X1070.Time spent watching television (TV),47754,-0.0618139643444506,0.0375702671523853,-0.135451687963126,0.0118237592742247,0.0999265428591942
CCND2,G1/S-specific cyclin-D2,Physical activities,X1080.Time spent using computer,45161,-0.0949951459540092,0.0379520008197347,-0.169381067560689,-0.0206092243473292,0.0123229265114439
CCND2,G1/S-specific cyclin-D2,Physical activities,X1090.Time spent driving,42910,0.0175072125347724,0.0419770924350984,-0.0647678886380204,0.0997823137075652,0.67663648567066
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1160.Sleep duration,48657,-0.0145926413065347,0.034680970165928,-0.0825673428317534,0.0533820602186841,0.673929033353063
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34727,-0.00103985120161764,0.0156381121279549,-0.0316905509724092,0.029610848569174,0.946986165676014
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34727,-0.00412171481053835,0.0174037373869503,-0.0382330400889609,0.0299896104678842,0.812797143196099
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34727,0.0352436125201626,0.0183893090403132,-0.000799433198851243,0.0712866582391764,0.055344483648342
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34727,-0.00919124176961182,0.0190394653105611,-0.0465085937783116,0.0281261102390879,0.629292745564302
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34727,-0.00284210274206677,0.019261690819006,-0.0405950167473186,0.0349108112631851,0.882701122610445
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34727,-0.0450324499968851,0.0520424755022445,-0.147035701981284,0.0569708019875141,0.386907017590224
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34727,0.0310887384783193,0.0649544091998429,-0.0962219035533728,0.158399380510011,0.632223227366477
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34727,0.0215604652333462,0.0310260599062082,-0.0392506121828218,0.0823715426495141,0.48713510863151
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34727,-0.00343064503078821,0.0241299864876781,-0.0507254185466372,0.0438641284850608,0.88694762467287
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34727,-0.0125660602528776,0.0159152120383411,-0.0437598758480261,0.0186277553422709,0.429813661938437
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34727,0.0427300994253111,0.0252857766562717,-0.0068300228209814,0.0922902216716036,0.0911004914552188
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34727,0.000369912049202194,0.0119300749364,-0.0230130348261417,0.0237528589245461,0.975265220062278
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34727,0.00643565721080608,0.0161227130515619,-0.0251648603702552,0.0380361747918673,0.689783967891969
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34727,0.0120780386626282,0.0255629662462623,-0.0380253751800458,0.0621814525053023,0.636599692056984
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34727,-0.0131187557015577,0.0236821956795316,-0.0595358592334397,0.0332983478303242,0.579633182159541
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34727,0.0477534469852035,0.0289027707951216,-0.00889598377323493,0.104402877743642,0.098542988169734
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34727,-0.0152665752793604,0.0287836589193523,-0.0716825467612908,0.04114939620257,0.595860528274449
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34727,0.000101989036673292,0.0182045118665864,-0.035578854221836,0.0357828322951825,0.995530133831926
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34727,0.00822435925441738,0.0178169902024075,-0.0266969415423013,0.043145660051136,0.64438310946241
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34727,-0.00219472820401686,0.0197634830876478,-0.0409311550558066,0.0365416986477729,0.911580599510965
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120040.Fatigue severity over the past week,34735,-0.0176955958732186,0.0652222548496808,-0.145531215378593,0.110140023632156,0.786160026704258
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34738,-0.0283248253117066,0.0640350691161116,-0.153833560779285,0.0971839101558721,0.658263832495993
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34737,0.0855249276752229,0.0709729281417082,-0.0535820114825252,0.224631866832971,0.228235915789962
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120098.Mobility problems today,34739,-0.0407053291421939,0.075428300318293,-0.188544797766048,0.10713413948166,0.589453923631357
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120099.Self-care problems today,34739,-0.0529740310099883,0.112834462690983,-0.274129577884315,0.168181515864339,0.638740045400658
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120100.Problems doing usual activities,34739,-0.129059890738156,0.0721431716110515,-0.270460507095817,0.0123407256195049,0.0736735989334905
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120101.Pain or discomfort today,34739,0.0532583984807773,0.0646396741288953,-0.0734353628118575,0.179952159773412,0.410012835633589
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120102.Anxiety or depression today,34739,-0.0274852497293824,0.0827111298863581,-0.189599064306644,0.13462856484788,0.739670975581291
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120103.Scale to indicate how health is today,34725,0.0024132723162913,0.00514919059941368,-0.00767914125855952,0.0125056858911421,0.639322051911
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34724,0.000495345745041699,0.0812939760923891,-0.158840847396041,0.159831538886124,0.995138506493205
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34722,-0.158560534880341,0.0856120211114523,-0.326360096258788,0.00923902649810537,0.0640620866760136
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34727,0.0649476067383999,0.0656323925327184,-0.063691882625728,0.193587096102528,0.322425216651029
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34732,-0.0370242988557752,0.0669796316651801,-0.168304376919528,0.0942557792079777,0.58044139783468
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34732,-0.0286881365112799,0.0957432023467335,-0.216344813110877,0.158968540088318,0.764464770226789
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34720,-0.0601729460970847,0.0913000601169552,-0.239121063926317,0.118775171732147,0.509876921201911
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34736,-0.0109670099494079,0.0874457301951986,-0.182360641131997,0.160426621233181,0.900199090098519
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34730,-0.0781690134578052,0.129802481878933,-0.332581877940514,0.176243851024904,0.54705325270334
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34698,-0.165468786037031,0.173499976570133,-0.505528740114492,0.17459116804043,0.340267911408089
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32400,-0.0304527303706624,0.0927472839923108,-0.212237406995591,0.151331946254267,0.742671993486026
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46461,-0.0214416033609885,0.0828895274882935,-0.183905077238044,0.141021870516067,0.795887549817822
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45431,0.034794297148516,0.048168462822951,-0.0596158899844679,0.1292044842815,0.470091805603947
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1289.Cooked vegetable intake,47844,-0.0453879984995783,0.0363336002755651,-0.116601855039686,0.0258258580405292,0.211606472467638
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47144,-0.0225090139657405,0.0370450451217126,-0.0951173024042972,0.0500992744728161,0.543452280682779
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1309.Fresh fruit intake,47743,-0.0493125501540064,0.0379995287743962,-0.123791626551823,0.0251665262438101,0.194401000200743
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1319.Dried fruit intake,46891,-0.0776672216005711,0.040545648362624,-0.157136692391314,0.001802249190172,0.0554379590140475
CCND2,G1/S-specific cyclin-D2,Health and medical history,X134.Number of self-reported cancers,48782,0.0276550199209466,0.0756573320311286,-0.120633350860065,0.175943390701959,0.714719694291575
CCND2,G1/S-specific cyclin-D2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48783,-0.0570123601178786,0.0362641798298618,-0.128090152584408,0.0140654323486505,0.115933810806652
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X136.Number of operations, self-reported",48783,-0.00451952768595596,0.0343655440368922,-0.0718759939982647,0.0628369386263528,0.895370540544493
CCND2,G1/S-specific cyclin-D2,Health and medical history,X137.Number of treatments or medications taken,48783,-0.0477100881742772,0.0353178946475977,-0.116933161683569,0.0215129853350143,0.176750375309893
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1438.Bread intake,48322,0.00818251209817085,0.00277065578753328,0.00275202675460563,0.0136129974417361,0.00314791235373382
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1458.Cereal intake,47748,-0.0135083991616281,0.0358414141231698,-0.0837575708430409,0.0567407725197847,0.70625686353425
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1488.Tea intake,48031,0.00290911289755849,0.00273239436733648,-0.002446380062421,0.00826460585753798,0.287036103665882
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1498.Coffee intake,47217,-0.0225281719023108,0.0358770295377895,-0.0928471497963782,0.0477908059917566,0.530059166128351
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1528.Water intake,47004,-0.0361608160425491,0.0361301374419309,-0.106975885428734,0.0346542533436355,0.316912920348561
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1568.Average weekly red wine intake,43980,-0.105379836249492,0.039341625115531,-0.182489421475933,-0.0282702510230517,0.00740128528626908
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43981,-0.0451631088756226,0.0413222239204981,-0.126154667759799,0.0358284500085537,0.274433039493728
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1588.Average weekly beer plus cider intake,44034,-0.0275147610533785,0.0412908530738221,-0.10844483307807,0.0534153109713129,0.505188071412289
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1598.Average weekly spirits intake,43977,0.047486352367916,0.0429698584832545,-0.0367345702592628,0.131707274995095,0.26912990485031
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1608.Average weekly fortified wine intake,44009,0.0757296117237493,0.0769219276609556,-0.0750373664917238,0.226496589939222,0.324885356648204
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1737.Childhood sunburn occasions,43446,-0.0272473634733779,0.0423458911855248,-0.110245310197007,0.0557505832502506,0.519943623080842
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1807.Father's age at death,43609,-0.000698774366095417,0.0031504091572166,-0.00687357631423995,0.00547602758204912,0.824469232698899
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1845.Mother's age,36064,-0.00978212029856394,0.00717351315752225,-0.0238422060873075,0.00427796549017968,0.17272066793922
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1873.Number of full brothers,48441,-0.0023710694390749,0.0345622176214339,-0.0701130159770854,0.0653708770989356,0.945306376918282
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1883.Number of full sisters,48442,0.0301449334609261,0.0346948068730573,-0.0378568880102662,0.0981467549321184,0.384934163962101
CCND2,G1/S-specific cyclin-D2,Physical measures,X20015.Sitting height,48604,-0.00117896061713126,0.00357056061519605,-0.00817725942291553,0.005819338188653,0.741260450974772
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20016.Fluid intelligence score,35142,0.0156745026916862,0.0592826751702522,-0.100519540642008,0.13186854602538,0.791477932482093
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20018.Prospective memory result,35441,-0.101446285099872,0.0774061926486175,-0.253162422691163,0.0502698524914178,0.190046859592339
CCND2,G1/S-specific cyclin-D2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35054,-0.0037312326864367,0.00472023821808833,-0.0129828995938898,0.00552043422101644,0.42927916617712
CCND2,G1/S-specific cyclin-D2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35056,-0.00167087158441684,0.00470417896685271,-0.0108910623594481,0.00754931919061447,0.722459773325499
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20023.Mean time to correctly identify matches,48534,-0.00166907745515719,0.00280115724532349,-0.00715934565599124,0.00382119074567686,0.551280316390161
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45848,0.00289341293922365,0.006277844286362,-0.00941116186204587,0.0151979877404932,0.644881362195585
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45475,0.00436622967684073,0.0139854394965177,-0.023045231736334,0.0317776910900154,0.754893722578641
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45442,0.0140132701302955,0.0183796301292563,-0.0220108049230469,0.0500373451836379,0.445811203996034
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45460,-0.0306804431754143,0.0166709616452323,-0.0633555280000695,0.00199464164924096,0.0657340908869294
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45484,0.0194519794550448,0.0110571894393891,-0.00222011184615782,0.0411240707562475,0.0785590165979959
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#2.Illnesses of father_Stroke,45625,0.0152649509524217,0.00798394077066098,-0.000383572958073806,0.0309134748629172,0.0558984844488853
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45583,-0.0106746024492516,0.0101598869490417,-0.0305879808693732,0.00923877597087007,0.293429016673528
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45489,-0.00612919501063687,0.0123604437406704,-0.0303556647423508,0.018097274721077,0.619991343011293
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45609,0.00803087655184584,0.00949894800459582,-0.010587061537162,0.0266488146408536,0.397872061739799
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45678,0.00324094702916982,0.0071027139989854,-0.0106803724088416,0.0171622664671812,0.648182229578784
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45553,0.0345579946928287,0.00973368481399005,0.0154799724574082,0.0536360169282492,0.000385760221940852
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46491,-0.00873647209661557,0.00747186480559024,-0.0233813271155724,0.00590838292234129,0.242318813269822
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46361,0.00456571185065903,0.010501289902096,-0.0160168163574491,0.0251482400587672,0.663730099727729
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46292,-0.0192200570511935,0.0237085799857749,-0.0656888738233122,0.0272487597209253,0.417560719412734
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46323,0.0240207837699646,0.0123858468236506,-0.000255476004390652,0.0482970435443198,0.0524717172696994
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46442,0.00688983306998075,0.0084323023327545,-0.00963747950221807,0.0234171456421796,0.413895825262344
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46361,0.00339631512373419,0.0141450940235946,-0.0243280691625113,0.0311206994099797,0.810251227788696
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46329,-0.0254633511090079,0.0126916986992498,-0.0503390805595375,-0.000587621658478255,0.0448394432775328
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46338,-0.00655130931910653,0.0108344439890056,-0.0277868195375574,0.0146842008993444,0.5454031937136
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46367,-0.00308223189490618,0.0126731184300393,-0.0279215440177832,0.0217570802279708,0.807845359481189
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46545,-0.00963570592682468,0.0064262342827457,-0.0222311251210063,0.00295971326735689,0.133779002983214
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46414,0.00200344987031635,0.00969037326383181,-0.016989681726794,0.0209965814674267,0.836210274423301
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43912,-0.00104705286817576,0.0102776025706184,-0.0211911539065878,0.0190970481702362,0.918855520495354
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43786,-0.0252578104806544,0.0419408072730223,-0.107461792735778,0.0569461717744693,0.547033243932808
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43782,0.00736279656417769,0.0409229882596468,-0.0728462604247301,0.0875718535530854,0.857219069509385
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43832,0.000992600498257929,0.013363715471192,-0.0252002818252783,0.0271854828217942,0.9407919174653
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43792,-0.0105605150928323,0.0239986513059582,-0.0575978716525104,0.0364768414668459,0.659909913164807
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43823,-0.0160820630384549,0.0171992514064072,-0.049792595795013,0.0176284697181032,0.349780270175272
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43799,0.0101361490233757,0.0196318351125386,-0.0283422477972,0.0486145458439513,0.605644135421513
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43805,-0.0349523939374668,0.0192164334530386,-0.0726166035054225,0.00271181563048899,0.0689493419840143
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43809,0.00687136103968656,0.015086415792387,-0.022698013913392,0.0364407359927651,0.64877997242015
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43825,0.0119533044003524,0.0192164103145074,-0.0257108598160822,0.049617468616787,0.533927326545806
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43967,-0.00581106430538223,0.00782972826530432,-0.0211573317053787,0.00953520309461424,0.457989892485259
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43886,-0.00267017689565216,0.0108377605746643,-0.0239121876219942,0.0185718338306898,0.805393577267657
CCND2,G1/S-specific cyclin-D2,Mental health,X20127.Neuroticism score,44830,0.0388310534699954,0.0360851678120983,-0.0318958754417173,0.109557982381708,0.281900966238934
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35142,-0.0254261231278405,0.059823450690539,-0.142680086481297,0.091827840225616,0.670836583192026
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20161.Pack years of smoking,35702,-0.00299158030841521,0.00474002537428265,-0.0122820300420092,0.00629886942517879,0.527974721102699
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35702,-0.00284592624714736,0.00467180472017485,-0.0120026634986901,0.00631081100439534,0.54243082788782
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20191.Fluid intelligence score,33266,0.0701426236447553,0.0660767175487998,-0.0593677427508924,0.199652990040403,0.288502774663959
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33267,-0.018906009282066,0.067402140778207,-0.151014205207352,0.11320218664322,0.779109704372668
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20240.Maximum digits remembered correctly,32833,-0.0422243124930948,0.071683172030238,-0.182723329672361,0.0982747046861717,0.555865400813239
CCND2,G1/S-specific cyclin-D2,Physical measures,X20255.Spirometry QC measure,42978,-0.0892954282122407,0.0438922476911842,-0.175324233686962,-0.00326662273751958,0.0419272065736622
CCND2,G1/S-specific cyclin-D2,Eye measures,X20261.avMSE,33123,-0.00378301997345796,0.00581934254253897,-0.0151889313568343,0.00762289140991843,0.5156755858762
CCND2,G1/S-specific cyclin-D2,Eye measures,X20262.Myopia diagnosis,33123,0.0595217781364654,0.0897729652048003,-0.116433233664943,0.235476789937874,0.507347924433083
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20280.Glucose-lactate,39735,-0.000982083031985161,0.00355449212109619,-0.0079488875893337,0.00598472152536337,0.782327783661584
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39754,-0.00472443449734735,0.00377140463503358,-0.0121163875820132,0.00266751858731847,0.21034156305598
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34827,-0.0318679127191244,0.0233021420774029,-0.0775401111908341,0.0138042857525853,0.1714879729801
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34827,0.0171098064052198,0.0504821444033432,-0.0818351966253329,0.116054809435773,0.734675485888708
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34830,0.0405293324198899,0.0604699474064705,-0.0779917644967923,0.159050429336572,0.502730126920701
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34830,-0.0345267881583354,0.0227553323522804,-0.0791272395688049,0.0100736632521342,0.129240339484385
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34830,0.0255367793375397,0.0317167627812529,-0.0366280757137159,0.0877016343887953,0.420763346589877
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34831,-0.0219472352676512,0.0439326812835614,-0.108055290583432,0.0641608200481292,0.617398960794567
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34831,-0.0239734106829496,0.028195091722971,-0.0792357904599728,0.0312889690940737,0.395208252228384
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34831,0.00250212955669086,0.0319300868378679,-0.0600808406455302,0.0650850997589119,0.937542016198217
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34831,-0.036199346938238,0.0470568722153959,-0.128430816480414,0.0560321226039381,0.441763376109096
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34831,-0.0803510530728046,0.0517824932367053,-0.181844739816747,0.0211426336711377,0.120784077260316
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34831,-0.00496081449364012,0.0338684988194854,-0.0713430721798315,0.0614214431925513,0.883552884252967
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34831,-0.0221921314329526,0.0500627122663312,-0.120315047474962,0.0759307846090566,0.657573809150704
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34831,-0.0243212918071543,0.0393059449700953,-0.101360943948541,0.0527183603342324,0.536091308153621
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34834,0.0302412307936451,0.0662970936675908,-0.0997010727948328,0.160183534382123,0.648300051436876
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34834,0.0046131398016936,0.0305308485947452,-0.0552273234440069,0.0644536030473941,0.879903566677717
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34834,0.00288775912007713,0.0384304056668111,-0.0724358359868726,0.0782113542270269,0.940103695441462
CCND2,G1/S-specific cyclin-D2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34834,-0.0312192378066379,0.0806173103524988,-0.189229166097536,0.12679069048426,0.698582664105141
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20600.Liking for adding salt to foods,35253,-0.126252450815503,0.0556503661000554,-0.235327168371611,-0.0171777332593939,0.0233201937856778
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20601.Liking for aniseed,35253,-0.00881562923280282,0.0554754197491791,-0.117547451941194,0.0999161934755882,0.873744181847982
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20602.Liking for apple juice,35253,0.0106337878868323,0.0548240288421589,-0.0968213086437991,0.118088884417464,0.846211428874904
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20603.Liking for apples,35253,0.0961681645867257,0.0552316808253659,-0.0120859298309915,0.204422259004443,0.0816987419910155
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20604.Liking for asparagus,35253,-0.0234108239837196,0.0567295526978156,-0.134600747271438,0.087779099303999,0.679858630010054
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20605.Liking for aubergine,35253,-0.0292939856107033,0.0551320178941467,-0.137352740683231,0.0787647694618241,0.595199204403563
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20606.Liking for avocados,35253,0.0163083315172015,0.0548153238941982,-0.0911297033154271,0.12374636634983,0.766083349859411
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20607.Liking for bacon,35253,-0.0301598665949936,0.0558837375867074,-0.13969199226494,0.0793722590749529,0.58942926629678
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20608.Liking for baked or steamed fish,35253,0.0524289625982715,0.0550151053535021,-0.0554006438945926,0.160258569091136,0.340628725155999
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20609.Liking for bananas,35253,0.00555026182842124,0.0567259290387468,-0.105632559087522,0.116733082744365,0.922059539036315
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35253,-0.0639109731260038,0.0550513097789147,-0.171811540292677,0.0439895940406689,0.245710185002221
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20611.Liking for beef steak,35253,-0.0295392423927959,0.0558439247255117,-0.138993334854799,0.079914850069207,0.596850372213144
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20612.Liking for beetroot,35253,0.0419229279482569,0.0564175193525618,-0.0686554099827641,0.152501265879278,0.45745739951964
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20613.Liking for bell pepper,35253,-0.041514286041678,0.0557488417253313,-0.150782015823327,0.0677534437399714,0.456499789255601
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20614.Liking for bicycling,35253,0.0149348302820919,0.0560285556154402,-0.0948811387241708,0.124750799288355,0.789818173736865
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20615.Liking for biscuits,35253,-0.0610488936100786,0.0556311412153802,-0.170085930392224,0.0479881431720667,0.272512004493857
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20616.Liking for bitter foods,35253,-0.0179725635991591,0.0554481842792606,-0.12665100478651,0.0907058775881917,0.745847857416643
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20617.Liking for bitter or ale,35253,-0.0327862223967197,0.0565504422772675,-0.143625089260164,0.0780526444667246,0.562089717834968
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20618.Liking for black olives,35253,-0.0170916666495082,0.0554594941974487,-0.125792275276508,0.0916089419774911,0.757952839834721
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20619.Liking for black pepper,35253,-0.0260860398316452,0.0553720219067329,-0.134615202768842,0.0824431231055513,0.637581177521386
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20620.Liking for blue cheese,35253,-0.0199666116876959,0.0548151786162456,-0.127404361775537,0.0874711384001454,0.715680433554101
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20621.Liking for bolognese sauce,35253,-0.0311291982204557,0.0569741655847085,-0.142798562766484,0.080540166325573,0.584827279775506
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20622.Liking for broad beans,35253,0.0548294397076545,0.0564346599052052,-0.0557824937065477,0.165441373121857,0.331306784946469
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20623.Liking for broccoli,35253,0.0488243185817497,0.0554371745190322,-0.0598325434755534,0.157481180639053,0.378504270551461
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20624.Liking for brown rice,35253,0.0478343344361877,0.0550249978472933,-0.0600146613445072,0.155683330216883,0.38470349646063
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20625.Liking for brussel sprouts,35253,0.0123629611921297,0.0548489107899572,-0.0951409039561864,0.119866826340446,0.82167480724707
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20626.Liking for burgers (meat),35253,-0.00933638279259238,0.05457022405783,-0.116294021945939,0.0976212563607543,0.864158739637912
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20627.Liking for burn of spicy foods,35253,0.0294347342005536,0.0544246834331619,-0.0772376453284438,0.136107113729551,0.5886399469778
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20628.Liking for butter on bread,35253,-0.0702092561185002,0.0554449123709671,-0.178881284365596,0.0384627721285952,0.205454199321412
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20629.Liking for butternut squash,35253,-0.0581942716693451,0.054917759154898,-0.165833079612945,0.049444536274255,0.289336841239848
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20630.Liking for cabbage,35253,-0.00743814407203473,0.0562784440041561,-0.117743894320181,0.102867606176111,0.89485633143025
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20631.Liking for cake,35253,0.0879383944835152,0.0564664310860863,-0.0227358104452139,0.198612599412244,0.119433366919204
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20632.Liking for cake icing,35253,-0.0351647466307406,0.0554068078627449,-0.143762090041721,0.0734325967802394,0.525668955882438
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20633.Liking for capers,35253,-0.0356325997170701,0.0542032325896052,-0.141870935592696,0.0706057361585562,0.510953703760284
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20634.Liking for cauliflower,35253,0.0789841528589225,0.0561737803923855,-0.0311164567101531,0.189084762427998,0.159750709750624
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20635.Liking for cereal or granola bar,35253,0.0279742879889838,0.0555013511298886,-0.0808083602255978,0.136756936203565,0.614257742796549
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20636.Liking for cheesecake,35253,0.144754402397776,0.0568382783833292,0.0333513767664508,0.256157428029101,0.0108946566753028
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20637.Liking for cherries,35253,0.0993021659381014,0.0554878139952779,-0.00945394949264317,0.208058281368846,0.0735603631805735
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20638.Liking for chicken,35253,0.10555677293409,0.0583747316952744,-0.00885770118864798,0.219971247056828,0.0706110251319105
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20639.Liking for chilli pepper,35253,-0.080543537458198,0.0555101986159409,-0.189343526745442,0.0282564518290461,0.146835903101478
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20640.Liking for chips or french fries,35253,-0.0319771193356545,0.0554087339666056,-0.140578237910202,0.0766239992388925,0.563882449242063
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20641.Liking for cigarette smoking,35253,-0.116707516550884,0.0875088806296379,-0.288224922584975,0.0548098894832057,0.182359443075422
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20642.Liking for cod,35253,0.0841666007181263,0.0564008409235324,-0.0263790474919972,0.19471224892825,0.135669734998287
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20643.Liking for coffee with sugar,35253,0.0500520177472,0.0581941353402569,-0.0640084875197036,0.164112523014104,0.3897721347375
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20644.Liking for coffee without sugar,35253,-0.0168208441738873,0.0570894523644518,-0.128716170808213,0.0950744824604381,0.768278001474538
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20645.Liking for coriander,35253,-0.0390181217557611,0.056410206594385,-0.149582126680756,0.0715458831692335,0.489159026001682
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20646.Liking for corn flakes,35253,0.037378058492357,0.0549869368904809,-0.0703963378129855,0.1451524547977,0.496678527889484
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20647.Liking for cream,35253,-0.00295230206630217,0.0558699443448477,-0.112457392982204,0.106552788849599,0.957859065312449
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20648.Liking for croissant,35253,0.0114437026669303,0.0549541491287389,-0.0962664296253979,0.119153834959259,0.835047241005109
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20649.Liking for cucumber,35253,0.0516365389133849,0.0568273118420041,-0.0597449922969431,0.163018070123713,0.363564127778527
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20650.Liking for curry,35253,-0.0813604106513021,0.0556029291069626,-0.190342151700949,0.0276213303983446,0.143449118661878
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20651.Liking for dairy products,35253,0.131391932489384,0.05754199873978,0.0186096149594156,0.244174250019353,0.0224376991042211
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20652.Liking for dark chocolate,35253,-0.0441208915599519,0.0569194664707528,-0.155683045842627,0.0674412627227237,0.438281033220813
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35253,-0.0403696015753651,0.0565182158313065,-0.151145304604726,0.0704061014539956,0.475081661441441
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20654.Liking for dried fruit,35253,0.0563005196699382,0.0563242238532205,-0.0540949590823739,0.16669599842225,0.3175506213622
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20655.Liking for eggs,35253,-0.038470944410572,0.0559299887067679,-0.148093722275837,0.071151833454693,0.491576869133681
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20656.Liking for exercising alone,35253,0.00337132210099807,0.0568035750998526,-0.107963685094713,0.114706329296709,0.952674702480379
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20657.Liking for exercising with others,35253,-0.0383754856167808,0.0564527961632255,-0.149022966096703,0.0722719948631411,0.496667412306185
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35253,-0.12478814661237,0.056260424695334,-0.235058579015225,-0.0145177142095151,0.026585462161146
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20659.Liking for fatty foods,35253,-0.00906308126441654,0.0559036950628193,-0.118634323587542,0.100508161058709,0.871216649834835
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20660.Liking for fresh tomatoes,35253,0.00998485444267906,0.0568460524113649,-0.101433408283596,0.121403117168954,0.860576409054534
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20661.Liking for fried chicken,35253,0.0641792567630863,0.0552139414877908,-0.0440400685529837,0.172398582079156,0.245125280661472
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20662.Liking for fried or battered fish,35253,0.0553944679281731,0.0558934341291247,-0.0541566629649113,0.164945598821258,0.321686075593734
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20663.Liking for fruit,35253,0.0390997933500988,0.0593326435841678,-0.0771921880748701,0.155391774775068,0.509923138563535
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20664.Liking for garlic,35253,-0.052300938937113,0.0564191527495129,-0.162882478326158,0.0582806004519322,0.353956669715785
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20665.Liking for gherkins,35253,-0.0344094365479357,0.0543013421975346,-0.140840067255103,0.0720211941592321,0.526314353618713
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20666.Liking for globe artichoke,35253,0.073928795752505,0.0564375445568672,-0.0366887915789546,0.184546383083965,0.190267425547689
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20667.Liking for goat's cheese,35253,0.0321330505118719,0.0546138888978194,-0.0749101717278541,0.139176272751598,0.556305484228954
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20668.Liking for going to a cafe,35253,0.0114525117949709,0.0554929425261712,-0.0973136555563246,0.120218679146266,0.836502128649974
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20669.Liking for going to the gym,35253,-0.0923899101405414,0.0554728325976798,-0.201116662031994,0.016336841750911,0.09586052136109
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20670.Liking for going to the pub,35253,-0.0486773042106381,0.0564158419100602,-0.159252354354356,0.0618977459330798,0.388261858026667
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20671.Liking for grapefruit,35253,0.0895003909612937,0.0543650792688529,-0.017055164405658,0.196055946328245,0.0997524819228382
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20672.Liking for green olives,35253,0.0276883326949737,0.0552738763983261,-0.0806484650457455,0.136025130435693,0.616437112659679
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20673.Liking for haddock,35253,0.0740543007736257,0.0559004471188469,-0.0355105755793141,0.183619177126566,0.185298556159653
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20674.Liking for ham,35253,-0.00387610250051107,0.0562749940417049,-0.114175090822253,0.106422885821231,0.945088895624678
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20675.Liking for hard cheese,35253,0.048702289090391,0.0560720678774532,-0.0611989639494172,0.158603542130199,0.385115956227125
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20676.Liking for herring,35253,0.0594867838015447,0.0557013968239127,-0.0496879539733243,0.168661521576414,0.285578004286954
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20677.Liking for honey,35253,-0.0673780233424638,0.0559301091205387,-0.17700103721872,0.0422449905337921,0.228368806580587
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35253,-0.0529962978482615,0.0543849963440251,-0.159590890682551,0.0535982949860277,0.329860981625435
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20679.Liking for ice cream,35253,0.0231582383948017,0.0557655988678256,-0.0861423353861365,0.13245881217574,0.677951656543063
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20680.Liking for jam,35253,0.0343132158535606,0.0554163592930867,-0.0743028483608893,0.14292928006801,0.535812900476117
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20681.Liking for kiwi fruit,35253,0.0691755685838566,0.0545375869011053,-0.0377181017423097,0.176069238910023,0.204698971445398
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20682.Liking for lager,35253,-0.0303872875993123,0.054359152712729,-0.136931226916261,0.0761566517176365,0.576174016956839
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20683.Liking for lamb,35253,-0.00235209282409289,0.0557081448536716,-0.111540056737289,0.106835871089103,0.966323229101654
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20684.Liking for lemons,35253,0.0190217155866975,0.0547290971025028,-0.088247314734208,0.126290745907603,0.72818069149661
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20685.Liking for lentils or beans,35253,0.0289538132656257,0.0566404295256609,-0.0820614286046697,0.139969055135921,0.609237576545863
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20686.Liking for liver,35253,0.0284770650028656,0.0550905861044172,-0.079500483761792,0.136454613767523,0.605233783216839
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20687.Liking for mackerel,35253,0.103185867262487,0.0557845810557618,-0.0061519116068065,0.21252364613178,0.0643982638273363
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20688.Liking for marzipan,35253,-0.0449100589741257,0.054729470683077,-0.152179821512957,0.0623597035647053,0.411913422219843
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20689.Liking for mayonnaise,35253,-0.179499286587259,0.0549842454574103,-0.287268407683784,-0.0717301654907352,0.00110189838672625
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20690.Liking for melon,35253,-0.0325425726596471,0.0564560145705013,-0.14319636121783,0.0781112158985354,0.564348500645343
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20691.Liking for milk chocolate,35253,0.0628482138270104,0.0552873408167161,-0.0455149741737531,0.171211401827774,0.255681318495633
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20692.Liking for mushrooms,35253,0.0383274426402508,0.0571705530143408,-0.0737268412678573,0.150381726548359,0.502622748353226
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20694.Liking for orange juice,35253,0.0432961457306326,0.0554893193027752,-0.0654629201028068,0.152055211564072,0.435265123471125
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20695.Liking for oranges,35253,0.0909732879767711,0.0577149321773625,-0.0221479790908594,0.204094555044402,0.11501530615138
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20696.Liking for pasta,35253,-0.00440369206587974,0.0558023963233557,-0.113776388859657,0.104969004727897,0.937101953633107
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20697.Liking for pears,35253,-0.0120813576572723,0.0561164304614636,-0.122069561361741,0.0979068460471963,0.829547120538127
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20698.Liking for pizza,35253,-0.0345285357963371,0.0556135676408667,-0.143531128372436,0.0744740567797617,0.534709534585324
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20699.Liking for plain yogurt,35253,0.0926871270475053,0.0563921569101113,-0.0178415004963129,0.203215754591324,0.100302584786363
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20700.Liking for plums,35253,0.116378192062522,0.0557843903445365,0.00704078698723007,0.225715597137813,0.0369972625827072
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20701.Liking for pollock,35253,-0.0517998408070573,0.0548738980688476,-0.159352681021999,0.055752999407884,0.345214393899047
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20702.Liking for pork chop,35253,0.0779635356347868,0.0549309509191498,-0.0297011281667468,0.18562819943632,0.15585828830335
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20703.Liking for porridge,35253,0.0718839210598661,0.0550200389544016,-0.0359553552907609,0.179723197410493,0.191426319140874
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20704.Liking for potato crisps,35253,-0.0624746894506568,0.0565479802986347,-0.173308730835981,0.0483593519346671,0.269282582812758
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20705.Liking for potatoes,35253,0.0208554264357853,0.05589488838065,-0.0886985547902887,0.130409407661859,0.709072024897893
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20706.Liking for prawns,35253,-0.00247224229955292,0.0555705564870889,-0.111390533014247,0.106446048415141,0.964516476057169
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20707.Liking for raw carrots,35253,0.00235405134954006,0.0560841241307751,-0.107570831946779,0.112278934645859,0.966521022628277
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20708.Liking for red meat,35253,-0.0210616384638909,0.056077768191442,-0.130974064119117,0.0888507871913354,0.707241810870868
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20709.Liking for red wine,35253,-0.0379194955919815,0.0565739610336889,-0.148804459218012,0.0729654680340488,0.502712737953618
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35253,-0.0737319867168112,0.0557283905520062,-0.182959632198743,0.0354956587651208,0.185861062178158
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20711.Liking for roast chicken,35253,0.0778816235248391,0.0582140773641341,-0.0362179681088637,0.191981215158542,0.180991575366141
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20712.Liking for salad dressing,35253,-0.0626971295485742,0.0548927964711616,-0.170287010632051,0.0448927515349027,0.253422825573621
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20713.Liking for salad leaves,35253,-0.0128354313857518,0.0559932336383265,-0.122582169316872,0.0969113065453683,0.818695790625468
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20714.Liking for salami,35253,0.00738100106912604,0.0545299050461106,-0.0994976128212507,0.114259614959503,0.892333768310226
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20715.Liking for salmon,35253,0.0828393776047891,0.0572130778605411,-0.0292982550018715,0.19497701021145,0.147689456231999
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20716.Liking for salty foods,35253,-0.13355106007376,0.0556500327019562,-0.242625124169594,-0.0244769959779261,0.0164296876999693
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20717.Liking for salty pretzels,35253,-0.0680980018433183,0.0557981526629158,-0.177462381062633,0.0412663773759967,0.222343442047149
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20718.Liking for sardines,35253,0.00901127734500618,0.055133813545944,-0.0990509972050441,0.117073551895056,0.870174028110121
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20719.Liking for sausages (meat),35253,-0.00333808013805017,0.0553241026141396,-0.111773321261764,0.105097160985663,0.951889196038634
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20720.Liking for savoury biscuits,35253,-0.0637616101302699,0.0557277141137433,-0.172987929793207,0.0454647095326669,0.252597102858326
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35253,-0.0547621786017977,0.0544842700245383,-0.161551347849893,0.0520269906462974,0.314884960571163
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20722.Liking for skimmed milk,35253,0.104827690233452,0.0549710901551014,-0.00291564647054639,0.212571026937451,0.0565688068388019
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20723.Liking for smoked fish,35253,0.0330190759896826,0.0552073517917794,-0.0751873335222049,0.14122548550157,0.54979892772557
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20724.Liking for soft cheese,35253,0.0117761224319239,0.0557178575042966,-0.0974308782764973,0.120983123140345,0.832618505866509
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20725.Liking for soy sauce,35253,-0.0522168176609545,0.0552418250407861,-0.160490794740895,0.0560571594189862,0.344570412752026
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20726.Liking for soya milk,35253,0.0378195541291989,0.0555857393212403,-0.0711284949404321,0.14676760319883,0.49628612221274
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20727.Liking for spicy foods,35253,-0.0395564505097911,0.0552502149037245,-0.147846871721091,0.068733970701509,0.474046723449817
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20728.Liking for spinach,35253,-0.0411079286114914,0.0552945288204297,-0.149485205099534,0.0672693478765509,0.457244204270221
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20729.Liking for spirits,35253,-0.00891684224878365,0.0552283087000968,-0.117164327300973,0.099330642803406,0.871740592425777
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20730.Liking for strawberries,35253,0.0446266699732396,0.0567430953064742,-0.0665897968274498,0.155843136773929,0.43162098262879
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35253,-0.0123734346813074,0.0562513796898276,-0.122626138873369,0.0978792695107546,0.82590378719433
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20732.Liking for sweet foods,35253,-0.00842862204442878,0.0563697738378637,-0.118913378766642,0.102056134677784,0.881144879580157
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20733.Liking for taking the stairs,35253,0.033403004672362,0.0561796791651188,-0.076709166491271,0.143515175835995,0.55214817553195
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20734.Liking for tea with sugar,35253,0.0826247163096269,0.0618405347518115,-0.0385827318039237,0.203832164423178,0.1815645803426
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20735.Liking for tea without sugar,35253,0.0325490027207485,0.0565525773050515,-0.0782940487971524,0.143392054238649,0.564936882585303
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20736.Liking for tomato ketchup,35253,0.00670163728700899,0.0549918494984918,-0.101082387730035,0.114485662304053,0.903008820491814
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20737.Liking for tinned tuna,35253,0.0364989446692888,0.0558596873499122,-0.0729860425365391,0.145983931875117,0.513518454126757
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20738.Liking for turnip (white),35253,-0.00538448731409483,0.0550704022531428,-0.113322475730255,0.102553501102065,0.922114215338157
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20739.Liking for vegetables,35253,0.0750313074150335,0.0567317724934941,-0.0361629666722151,0.186225581502282,0.186026477814542
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20740.Liking for vinegar,35253,0.0410244144105406,0.055087186790232,-0.0669464716983143,0.148995300519395,0.456468612084028
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20741.Liking for watching television,35253,-0.118468320448212,0.0561578107773829,-0.228537629571882,-0.00839901132454113,0.0349335008907384
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20742.Liking for whisky,35253,-0.0453213379052889,0.0561347582562282,-0.155345464087496,0.0647027882769183,0.41948411376321
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20743.Liking for white bread,35253,-0.00121606329388416,0.0550854848056407,-0.10918361351294,0.106751486925172,0.982388049986999
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20744.Liking for white rice,35253,-0.0263979406405902,0.0556033317837606,-0.135380470936761,0.0825845896555806,0.634977460393836
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20745.Liking for white wine,35253,-7.71073285968092e-05,0.0548481628142635,-0.107579506444553,0.10742529178736,0.99887835054708
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35253,-0.0102167534449855,0.0553888045277651,-0.118778810319405,0.098345303429434,0.853661992799782
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20747.Liking for whole milk,35253,0.0790379757855487,0.0547715321523341,-0.0283142272330261,0.186390178804123,0.149053960369012
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20748.Liking for wholemeal bread,35253,0.0641192879750641,0.0560104044431191,-0.0456611047334493,0.173899680683578,0.252343779402556
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20749.Liking for working up a sweat,35253,0.00361964775797269,0.0575006420047823,-0.109081610571401,0.116320906087346,0.949808457656919
CCND2,G1/S-specific cyclin-D2,Physical measures,X21001.Body mass index (BMI),48662,0.032596014028934,0.0143260950146286,0.00451686780026203,0.0606751602576059,0.0228990668853459
CCND2,G1/S-specific cyclin-D2,Physical measures,X21002.Weight,48688,-0.00755281551346441,0.00689535654561187,-0.0210677143428637,0.00596208331593485,0.273377305846375
CCND2,G1/S-specific cyclin-D2,Physical measures,X21021.Pulse wave Arterial Stiffness index,35427,0.0022730557207313,0.00503129691464832,-0.00758828623197941,0.012134397673442,0.651439482693047
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35085,0.038874554919023,0.0632565169162672,-0.0851082182368608,0.162857328074907,0.538870779424827
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35088,0.0137031561227827,0.0648225867929565,-0.113349113991412,0.140755426236977,0.832585876501616
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35089,0.019083788503026,0.0624192290820905,-0.103257900497871,0.141425477503923,0.759815679157372
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21040.Satisfaction with bowel habits,35065,-0.0207509611620131,0.0577785461989092,-0.133996911711875,0.0924949893878489,0.719497261270603
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35061,0.00612144170332877,0.0638063682653561,-0.118939040096769,0.131181923503427,0.923572963624327
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21042.Greatest number of times bowels opened per day,35060,0.0299381387284486,0.0626248199204042,-0.0928065083155435,0.152682785772441,0.63262689227605
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21043.Least number of times bowels opened per week,35034,0.0691769653143477,0.0626050804984776,-0.0535289924626683,0.191882923091364,0.269212325041573
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21044.Average number of times bowels opened per day,35043,0.051688399309253,0.0685493285567346,-0.0826682846619467,0.186045083280453,0.450857491728786
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35092,-0.0282213392980605,0.0631153765342301,-0.151927477305152,0.0954847987090306,0.654789701335022
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35087,-0.0808685873295466,0.0631420502011923,-0.204627005723884,0.0428898310647903,0.200330588256622
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35091,0.159738855268921,0.0726250951340635,0.0173936688061567,0.302084041731685,0.0278775667125912
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35091,-0.0431935634874543,0.0913708638762129,-0.222280456684831,0.135893329709923,0.636423161729079
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35090,0.0856696547510773,0.0767451696979413,-0.0647508778568878,0.236090187359042,0.264340529209045
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35088,0.291199865760569,0.179067559016235,-0.0597725499112509,0.642172281432388,0.103955449822627
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35092,-0.0843725894331087,0.0786842545967762,-0.23859372844279,0.0698485495765727,0.283628234402201
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35090,-0.0479289991043498,0.0716337421511019,-0.18833113372051,0.0924731355118099,0.503465624151451
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34965,0.016923624313111,0.0715432269174082,-0.123301100445009,0.157148349071231,0.813012725439536
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35088,-0.053729857819963,0.0648497510596143,-0.180835369896807,0.0733756542568811,0.407401823272886
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35091,-0.0349610410963672,0.111388331024835,-0.253282169905045,0.18336008771231,0.75363268930674
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35092,0.0158400087567261,0.0633047434516276,-0.108237288408464,0.139917305921916,0.802426410332368
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35092,-0.0186737844191598,0.0628418248493275,-0.141843761123842,0.104496192285522,0.766357417612697
CCND2,G1/S-specific cyclin-D2,Working and living environment,X21100.Water hardness (USGS classification),48550,0.00257591177476568,0.0351167158483522,-0.0662528512880046,0.071404674837536,0.941526058923392
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2139.Age first had sexual intercourse,46159,0.00227926387581458,0.00283316459863711,-0.00327373873751416,0.00783226648914332,0.421122634236887
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2149.Lifetime number of sexual partners,44703,-0.032115016362419,0.0396123105463953,-0.109755145033354,0.0455251123085158,0.417530869923981
CCND2,G1/S-specific cyclin-D2,Physical activities,X22032.IPAQ activity group,45450,0.0630515439775002,0.0377838986618716,-0.0110048973997681,0.137107985354768,0.0951872829824177
CCND2,G1/S-specific cyclin-D2,Physical activities,X22033.Summed days activity,45786,0.00462675567238371,0.00282546297598334,-0.000911151760543642,0.0101646631053111,0.101539909748539
CCND2,G1/S-specific cyclin-D2,Physical activities,X22034.Summed minutes activity,45450,0.00472488076897951,0.00285603935232929,-0.000872956361585899,0.0103227178995449,0.0980756089582385
CCND2,G1/S-specific cyclin-D2,Physical activities,X22037.MET minutes per week for walking,44852,0.00314429648458864,0.0029268147212075,-0.00259226036897806,0.00888085333815533,0.282701220304829
CCND2,G1/S-specific cyclin-D2,Physical activities,X22038.MET minutes per week for moderate activity,45450,0.006493905271923,0.0028984116823976,0.000813018374423708,0.0121747921694223,0.0250711474509334
CCND2,G1/S-specific cyclin-D2,Physical activities,X22039.MET minutes per week for vigorous activity,45450,0.0211013598922163,0.0378860564247039,-0.0531553107002033,0.095358030484636,0.577555990849285
CCND2,G1/S-specific cyclin-D2,Physical activities,X22040.Summed MET minutes per week for all activity,44852,0.00569302054830632,0.00289494245430596,1.89333378666371e-05,0.011367107758746,0.0492532404145863
CCND2,G1/S-specific cyclin-D2,Eye measures,X2217.Age started wearing glasses or contact lenses,45493,-0.00519602673269784,0.00291951690867442,-0.0109182798736997,0.000526226408304026,0.0751339294344585
CCND2,G1/S-specific cyclin-D2,Working and living environment,X22501.Year ended full time education,33237,0.0143627546731335,0.0133169204177383,-0.0117384093456335,0.0404639186919005,0.280851508982202
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X22506.Tobacco smoking,33205,0.148345565166363,0.139282234624949,-0.124647614698536,0.421338745031263,0.286899353455483
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47522,0.145535231249488,0.111320189561201,-0.0726523402904656,0.363722802789442,0.191107373433052
CCND2,G1/S-specific cyclin-D2,Physical measures,X23098.Weight,48310,-0.00627805550343921,0.00696079733135435,-0.0199212182728937,0.00736510726601531,0.367112434625864
CCND2,G1/S-specific cyclin-D2,Physical measures,X23099.Body fat percentage,48279,-0.0229222040564919,0.00622759219757751,-0.0351282847637438,-0.01071612334924,0.000233170818003058
CCND2,G1/S-specific cyclin-D2,Physical measures,X23100.Whole body fat mass,48241,-0.0226742780534172,0.0062280838246141,-0.0348813223496608,-0.0104672337571735,0.00027264816239316
CCND2,G1/S-specific cyclin-D2,Physical measures,X23101.Whole body fat-free mass,48306,0.00878768125833097,0.0060205131198351,-0.00301252445654582,0.0205878869732078,0.144409571018771
CCND2,G1/S-specific cyclin-D2,Physical measures,X23102.Whole body water mass,48310,0.00866893172838484,0.00600525133188442,-0.00310136088210863,0.0204392243388783,0.148879093145997
CCND2,G1/S-specific cyclin-D2,Physical measures,X23104.Body mass index (BMI),48310,0.0295830963621097,0.0141473428453863,0.00185430438515267,0.0573118883390668,0.0365344847272993
CCND2,G1/S-specific cyclin-D2,Physical measures,X23105.Basal metabolic rate,48310,0.00699107130909917,0.00625025407227874,-0.00525942667256717,0.0192415692907655,0.263356066112553
CCND2,G1/S-specific cyclin-D2,Physical measures,X23106.Impedance of whole body,48310,-0.023227288704407,0.00492024410322166,-0.0328709671467215,-0.0135836102620926,2.36580857346755e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23107.Impedance of leg (right),48310,-0.0231744185463181,0.00398080218098842,-0.0309767908210554,-0.0153720462715808,5.92110253304066e-09
CCND2,G1/S-specific cyclin-D2,Physical measures,X23108.Impedance of leg (left),48310,-0.0187884650532578,0.00396324297018749,-0.0265564212748253,-0.0110205088316904,2.144906626695e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23109.Impedance of arm (right),48310,-0.01783145062683,0.00488401754947011,-0.0274041250237914,-0.00825877622986858,0.000261917170627129
CCND2,G1/S-specific cyclin-D2,Physical measures,X23110.Impedance of arm (left),48310,-0.0148545740414629,0.00487748267806174,-0.0244144400904639,-0.00529470799246194,0.00232568708256153
CCND2,G1/S-specific cyclin-D2,Physical measures,X23111.Leg fat percentage (right),48310,-0.0247479760904489,0.00633607586382569,-0.0371666847835472,-0.0123292673973505,9.41946933029438e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23112.Leg fat mass (right),48310,-0.0332965268261013,0.00681946336502051,-0.0466626750215415,-0.0199303786306611,1.05530214906938e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23113.Leg fat-free mass (right),48309,0.014277603369294,0.00660429420040081,0.0013331867365084,0.0272220200020796,0.0306404528886995
CCND2,G1/S-specific cyclin-D2,Physical measures,X23114.Leg predicted mass (right),48309,0.0140962041041739,0.0066532770465621,0.00105578109291223,0.0271366271154357,0.0341294978620077
CCND2,G1/S-specific cyclin-D2,Physical measures,X23115.Leg fat percentage (left),48309,-0.0184850787887006,0.00662150827807448,-0.0314632350137265,-0.00550692256367459,0.0052486959759573
CCND2,G1/S-specific cyclin-D2,Physical measures,X23116.Leg fat mass (left),48309,-0.0241814668819529,0.00722561806950664,-0.0383436782981859,-0.0100192554657199,0.000819533443333362
CCND2,G1/S-specific cyclin-D2,Physical measures,X23117.Leg fat-free mass (left),48308,0.00755614677228976,0.00718019838359251,-0.00651704205955155,0.0216293356041311,0.292647750049282
CCND2,G1/S-specific cyclin-D2,Physical measures,X23118.Leg predicted mass (left),48308,0.00820624230038352,0.00723718756422233,-0.00597864532549225,0.0223911299262593,0.256850560693193
CCND2,G1/S-specific cyclin-D2,Physical measures,X23119.Arm fat percentage (right),48308,-0.0147906502936982,0.00700675962581824,-0.028523899160302,-0.00105740142709448,0.0347924695934841
CCND2,G1/S-specific cyclin-D2,Physical measures,X23120.Arm fat mass (right),48307,-0.0184127968128205,0.00765026514421028,-0.0334073164954726,-0.00341827713016831,0.016101320900873
CCND2,G1/S-specific cyclin-D2,Physical measures,X23121.Arm fat-free mass (right),48306,0.00858110995701786,0.00659666137647336,-0.00434834634086991,0.0215105662549056,0.193333162130298
CCND2,G1/S-specific cyclin-D2,Physical measures,X23122.Arm predicted mass (right),48306,0.00844522236051266,0.00662969668415446,-0.00454898314043008,0.0214394278614554,0.202732501094218
CCND2,G1/S-specific cyclin-D2,Physical measures,X23123.Arm fat percentage (left),48304,-0.0135972792101048,0.0065863585011023,-0.0265065418722653,-0.000688016547944247,0.0389870992123725
CCND2,G1/S-specific cyclin-D2,Physical measures,X23124.Arm fat mass (left),48304,-0.0160292888061328,0.00732878266002488,-0.0303937028197815,-0.00166487479248399,0.028741876481131
CCND2,G1/S-specific cyclin-D2,Physical measures,X23125.Arm fat-free mass (left),48300,0.00536463290269555,0.00601332383678388,-0.00642148181740086,0.017150747622792,0.372337155913717
CCND2,G1/S-specific cyclin-D2,Physical measures,X23126.Arm predicted mass (left),48299,0.00695734410041055,0.00604524591149027,-0.00489133788611038,0.0188060260869315,0.249796155696987
CCND2,G1/S-specific cyclin-D2,Physical measures,X23127.Trunk fat percentage,48298,-0.0182731403188672,0.0052769378635049,-0.0286159385313368,-0.00793034210639757,0.000535660347259162
CCND2,G1/S-specific cyclin-D2,Physical measures,X23128.Trunk fat mass,48298,-0.019786397959304,0.00555907836813729,-0.0306821915608531,-0.00889060435775494,0.0003727269786766
CCND2,G1/S-specific cyclin-D2,Physical measures,X23129.Trunk fat-free mass,48297,0.00674232115330231,0.00522721223277258,-0.00350301482293194,0.0169876571295366,0.197117790794578
CCND2,G1/S-specific cyclin-D2,Physical measures,X23130.Trunk predicted mass,48295,0.00631774108394951,0.00522863049269472,-0.00393037468173215,0.0165658568496312,0.226947362320088
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23400.Total Cholesterol,39757,0.0218986815529064,0.00377677545343367,0.0144962016641764,0.0293011614416364,6.88288057595027e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39757,0.019465436017784,0.00368533012399129,0.012242188974761,0.0266886830608069,1.30277826303869e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39757,0.0213133709232331,0.00370218875146991,0.0140570809703521,0.0285696608761141,8.78981067658783e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23403.VLDL Cholesterol,39757,0.0179417293365984,0.00380345858985056,0.0104869505004913,0.0253965081727055,2.41996808498896e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39757,0.0172925064181755,0.0036772423084564,0.0100851114936009,0.02449990134275,2.5998115744206e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23405.LDL Cholesterol,39757,0.0169890779342103,0.00365861599416851,0.00981819058564006,0.0241599652827806,3.46332564935082e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23406.HDL Cholesterol,39757,0.0148476234441062,0.00417707793276483,0.0066605506958871,0.0230346961923252,0.000380195366974599
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23407.Total Triglycerides,39757,0.0101481687250957,0.00385840008878775,0.0025857045510717,0.0177106328991197,0.00854645365746028
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23408.Triglycerides in VLDL,39757,0.00897634586735646,0.00391084503964081,0.00131108958966047,0.0166416021450524,0.0217375787195893
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23409.Triglycerides in LDL,39757,0.0132372454153619,0.00365070954781852,0.00608185470163757,0.0203926361290862,0.000289197496287915
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23410.Triglycerides in HDL,39757,0.0112107098802581,0.00378454553616459,0.00379300062937554,0.0186284191311407,0.00306059443170125
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39757,0.0237847845944016,0.00379213920279682,0.0163521917569199,0.0312173774318834,3.69324890631305e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23412.Phospholipids in VLDL,39757,0.0149891560998991,0.0038375204696423,0.00746761597940016,0.022510696220398,9.44100827211521e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23413.Phospholipids in LDL,39757,0.0171765073715608,0.0036728489276463,0.00997772347337406,0.0243752912697476,2.9506894299677e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23414.Phospholipids in HDL,39757,0.015798743857627,0.00399079495425809,0.00797678574728116,0.0236207019679729,7.57958809091927e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23415.Total Esterified Cholesterol,39757,0.0216857313436771,0.00379803343371609,0.0142415858135936,0.0291298768737607,1.16046963465308e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39757,0.0186942550083091,0.00378650750765681,0.0112727002933017,0.0261158097233164,8.04524167531961e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39757,0.0171348333373112,0.00365704969242471,0.00996701594015881,0.0243026507344637,2.82681608266771e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39757,0.0129795514846397,0.00417812808491246,0.00479042043821131,0.0211686825310682,0.00189761168635663
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23419.Total Free Cholesterol,39757,0.02195366874524,0.00372780006580401,0.0146471806162642,0.0292601568742159,3.9932043200288e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39757,0.0162788843749933,0.00382384010895319,0.00878415776144505,0.0237736109885415,2.08688928547599e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23421.Free Cholesterol in LDL,39757,0.0159966440361216,0.00367880870975651,0.00878617896499879,0.0232071091072443,1.38400315276804e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23422.Free Cholesterol in HDL,39757,0.0200746525118301,0.00415011664630688,0.0119404238850687,0.0282088811385916,1.33488599937556e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39757,0.0214799431988203,0.00364095567409357,0.0143436700775969,0.0286162163200437,3.75114662006321e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23424.Total Lipids in VLDL,39757,0.0132029184945465,0.0038373695331397,0.00568167420959263,0.0207241627795003,0.000582514858751085
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23425.Total Lipids in LDL,39757,0.0174004290343666,0.00366039419176137,0.0102260564185143,0.0245748016502189,2.02220284580698e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23426.Total Lipids in HDL,39757,0.0163017890863067,0.00406050340836882,0.00834320240590381,0.0242603757667096,5.99055761942955e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39757,0.016296561647592,0.00386140041454536,0.00872821683508311,0.0238649064601009,2.45825532976029e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23428.Concentration of VLDL Particles,39757,0.0172296988085709,0.0037913490223203,0.00979865472482308,0.0246607428923186,5.56505340469357e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23429.Concentration of LDL Particles,39757,0.017289260433225,0.00367392533542553,0.010088366775791,0.0244901540906591,2.55740734084057e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23430.Concentration of HDL Particles,39757,0.0138101684842246,0.00386236627378583,0.00623993058760432,0.0213804063808448,0.000350940478540886
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39757,0.000185847781705232,0.00396977222174292,-0.00759490577291088,0.00796660133632135,0.962660930516904
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39757,0.00777475733436349,0.00378839622841829,0.000349500726663649,0.0152000139420633,0.0401681105547236
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39757,0.013677517349409,0.00415266298308752,0.00553829790255744,0.0218167367962605,0.000991950695830478
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23434.Phosphoglycerides,39747,0.0217731091776222,0.00379992230638849,0.0143252614571007,0.0292209568981436,1.03104052404238e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39747,0.000463152928292967,0.00406715419644358,-0.00750846929673645,0.00843477515332239,0.909337814979245
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23436.Total Cholines,39747,0.0228906661350913,0.00386621776516597,0.015312879315366,0.0304684529548166,3.30050227491926e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23437.Phosphatidylcholines,39747,0.0229271967739141,0.00387956694235908,0.0153232455668904,0.0305311479809379,3.52695107429588e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23438.Sphingomyelins,39747,0.0211995717951792,0.003907039428248,0.0135417745158131,0.0288573690745453,5.88388139397719e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23439.Apolipoprotein B,39757,0.018553662135988,0.00368857087679817,0.0113240632174636,0.0257832610545124,4.98004667331406e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23440.Apolipoprotein A1,39757,0.0148314965212767,0.00397579371041757,0.00703894084885831,0.0226240521936952,0.000192086219265608
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39757,0.00932642259052819,0.00375337602183512,0.00196980558773134,0.016683039593325,0.012976642143477
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23442.Total Fatty Acids,39747,0.0171806894182103,0.0035417130635578,0.010238931813637,0.0241224470227836,1.2453107592494e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23443.Degree of Unsaturation,39747,-0.00189568848184758,0.00382394945758797,-0.00939062941872,0.00559925245502484,0.62008693794062
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39747,0.00496378484352171,0.00372590835158749,-0.00233899552558978,0.0122665652126332,0.182810272854351
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39747,0.0199508347833808,0.00366579532494984,0.0127658759464791,0.0271357936202825,5.36713716834123e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39747,0.0187076056686195,0.00368539170771756,0.0114842379214931,0.0259309734157459,3.91370948816346e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39747,0.0132557119597654,0.00360269863474132,0.00619442263567238,0.0203170012838584,0.000234899397920993
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23448.Saturated Fatty Acids,39747,0.0172141226050316,0.00349480979673533,0.0103642954034304,0.0240639498066329,8.52982354640666e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23449.Linoleic Acid,39747,0.0195004790561224,0.00365979039510426,0.0123272898817181,0.0266736682305268,1.01065602220921e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23450.Docosahexaenoic Acid,39747,0.00370365142302753,0.00369991552928614,-0.00354818301437329,0.0109554858604284,0.316843835906496
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39747,-0.00450540045513185,0.00373119829142078,-0.0118185491063166,0.00280774819605289,0.227267480790721
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39747,-0.00562216536630375,0.00365361927244234,-0.0127832591402907,0.00153892840768324,0.123883116006716
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39747,-0.00709919177449323,0.00373876901180403,-0.0144271790376291,0.000228795488642661,0.0576159700356889
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39747,0.00132237630622363,0.00394179737422204,-0.00640354654725157,0.00904829915969882,0.737272763026532
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39747,0.00921858096766637,0.00341354992240561,0.00252802311975136,0.0159091388155814,0.00693222511926508
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39747,0.00326566462643187,0.00374222546013031,-0.00406909727542353,0.0106004265282873,0.382870988233858
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39747,-0.00668998407763897,0.0036493143669227,-0.0138426402368075,0.000462672081529517,0.0667970020360885
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39747,-0.00380069525097669,0.00389476633595154,-0.0114344372694417,0.00383304676748834,0.3291615670804
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39747,0.00298375333411467,0.0036847929740409,-0.00423844089500549,0.0102059475632348,0.418102372631965
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23460.Alanine,39754,-0.0020073336747167,0.00368800853876765,-0.0092358304107013,0.0052211630612679,0.586255137947391
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23461.Glutamine,39721,-0.0042488954282827,0.00361703437330998,-0.0113382827999703,0.00284049194340486,0.240143767121181
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23462.Glycine,39744,-0.00508103022724915,0.00437543185848649,-0.0136568766698827,0.00349481621538437,0.245559546152177
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23463.Histidine,39743,0.00434297519898341,0.00364146272504903,-0.00279429174211269,0.0114802421400795,0.23303351889299
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39747,-0.00252506126358726,0.00407812238547347,-0.0105181811391153,0.00546805861194075,0.535815374837631
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23465.Isoleucine,39755,-0.000112896290991765,0.00393337447034132,-0.00782231025286075,0.00759651767087722,0.977102657722718
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23466.Leucine,39755,-0.00468759177273168,0.00403204952388338,-0.0125904088395431,0.00321522529407974,0.245023648508246
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23467.Valine,39747,-0.00178677841081548,0.0040593598443501,-0.00974312370574168,0.00616956688411072,0.659827874716922
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23468.Phenylalanine,39750,0.00898134221838831,0.00372672866314826,0.00167695403861771,0.0162857303981589,0.0159694758780125
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23469.Tyrosine,39745,0.00854060083800909,0.00387643210895598,0.00094279390445537,0.0161384077715628,0.0276002106946435
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23470.Glucose,39739,0.000724670439724104,0.00354771010504342,-0.00622884136616101,0.00767818224560922,0.838150715970243
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23471.Lactate,39741,-0.00144517034128467,0.00374748622497817,-0.00879024334224189,0.00589990265967255,0.699772692894036
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23472.Pyruvate,39718,0.000371155358134359,0.0035780215659743,-0.00664176691117527,0.00738407762744399,0.917383896746457
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23473.Citrate,39755,-0.000705059269601267,0.00370034546040812,-0.00795773637200119,0.00654761783279865,0.848890433499988
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23474.3-Hydroxybutyrate,39530,-0.00686335157295255,0.00412144577843219,-0.0149413852986796,0.00121468215277454,0.095886033138903
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23475.Acetate,39745,0.00586046702407572,0.00351918779417633,-0.00103714105250989,0.0127580751006613,0.0958830880260235
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23476.Acetoacetate,39756,-5.35760891323348e-05,0.00373027842208661,-0.00736492179642209,0.00725776961815742,0.988541041217334
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23477.Acetone,39756,-0.00708613233647444,0.00368886300507237,-0.0143163038264163,0.000144039153467408,0.0547630932849799
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23478.Creatinine,39551,0.00731654952978142,0.00458462650282314,-0.00166931841575192,0.0163024174753148,0.110542699729968
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23479.Albumin,39755,0.0025114087998758,0.0036761739649964,-0.00469389217151715,0.00971670977126875,0.494520999963737
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23480.Glycoprotein Acetyls,39757,0.00810233266852105,0.00382783819274175,0.000599769810747223,0.0156048955262949,0.0343085566993771
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39757,0.00691118651293739,0.00388428539730193,-0.000702012865774404,0.0145243858916492,0.0752229749763334
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39757,0.00612880353592311,0.00385669475485642,-0.00143031818359547,0.0136879252554417,0.112058549566332
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39757,0.00550407533611458,0.0039889347689527,-0.00231423681103272,0.0133223874832619,0.167664831533512
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39757,0.0071372766894861,0.00392362925695541,-0.000553036654146503,0.0148275900331187,0.0689306386248052
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39757,0.00745234192456649,0.00391938886840448,-0.000229660257506284,0.0151343441066393,0.0572748447178938
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39757,0.00710737766974083,0.00389744507249005,-0.000531614672339681,0.0147463700118213,0.0682394304830604
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39757,0.00634798309004717,0.00378161452724627,-0.00106398138335552,0.0137599475634499,0.0932495244773097
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39757,0.00878499656982616,0.0040350084038151,0.000876380098348565,0.0166936130413038,0.0294869739312302
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39757,0.00859278972735044,0.00400717440584531,0.000738727891893628,0.0164468515628072,0.0320262862897725
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39757,0.00941819261160924,0.0040049477898839,0.0015684949434368,0.0172678902797817,0.0187081810179592
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39757,0.011695959868035,0.00398374262399288,0.003887824325009,0.0195040954110611,0.00333236111131352
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39757,0.0127895132623334,0.00398206183397321,0.00498467206774594,0.0205943544569209,0.00132288792558214
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39757,0.0103214408932343,0.00397318135739645,0.00253400543273724,0.0181088763537313,0.00939525583117397
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39757,0.00702311757146323,0.00401655648652215,-0.000849333142120185,0.0148955682850466,0.0803977267761415
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39757,0.010016927032724,0.00397431063238589,0.0022272781932476,0.0178065758722003,0.0117353624263067
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39757,0.00987805174100709,0.00396066581419382,0.00211514674518721,0.017640956736827,0.012644256692093
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39757,0.00953164429799967,0.00404190055367708,0.0016095192127926,0.0174537693832067,0.0183805293019435
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39757,0.0125430490818182,0.00399454900477091,0.00471373303246726,0.0203723651311692,0.00169364915930622
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39757,0.0142868250084727,0.00396670839764286,0.00651207654909271,0.0220615734678527,0.000317537698749525
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39757,0.0106275921867068,0.00402988092845997,0.00272902556692526,0.0185261588064883,0.00837100109008347
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39757,0.00838838658023122,0.00389924917109858,0.000745858204877999,0.0160309149555844,0.0314753094110649
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39757,0.017097550587671,0.00375873697134647,0.00973042612383191,0.0244646750515101,5.45349644927424e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39757,0.0158161435418266,0.00376458711012767,0.00843755280597637,0.0231947342776768,2.67456190187549e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39757,0.0174268022631563,0.00375214196446151,0.0100726040128117,0.0247810005135009,3.44806117604532e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39757,0.0178635320830065,0.00369319369724989,0.0106248724363968,0.0251021917296163,1.33656464299816e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39757,0.0166417087819013,0.00368499023960543,0.0094191279122746,0.0238642896515279,6.36412706468337e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39757,0.018028647853002,0.00373350958348011,0.0107109690693809,0.025346326636623,1.39130789547392e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39757,0.0109573903126073,0.00385754635019377,0.00339659946622754,0.0185181811589871,0.00451233249506659
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39757,0.0136024038841837,0.00387382469212983,0.00600970748760927,0.0211951002807582,0.000447576783953992
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39757,0.0149907104806044,0.00387845434096303,0.00738893997231685,0.0225924809888919,0.000111661591794359
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39757,0.0169146237152566,0.00380952442222142,0.00944795584770267,0.0243812915828106,9.07863687410061e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39757,0.0167154185533358,0.00384548678611956,0.00917826445254147,0.0242525726541302,1.39385631593444e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39757,0.0161425145067964,0.00391232301511475,0.00847436139717148,0.0238106676164213,3.716962213076e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39757,0.0173753501167591,0.00374274467807062,0.0100395705477407,0.0247111296857775,3.48299501759421e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39757,0.00921817680703768,0.00391084693645375,0.00155291681158832,0.016883436802487,0.0184364851318449
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39757,0.0215313408026893,0.00372040585197171,0.0142393453328248,0.0288233362725539,7.34248108739511e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39757,0.021974237389838,0.00374306075427389,0.0146378383114612,0.0293106364682149,4.46426944169479e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39757,0.0205583720318004,0.00372743328711961,0.0132526027890459,0.0278641412745548,3.55695885913376e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39757,0.0234810212114123,0.00377211716191161,0.0160876715740655,0.0308743708487591,4.99194034556355e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39757,0.0236832864273378,0.00379993994797802,0.0162354041293009,0.0311311687253747,4.75487074011822e-10
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39757,0.0219894744770277,0.00373492305917178,0.014669025281051,0.0293099236730044,4.03300934990799e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39757,0.0114984106576466,0.00380477582323078,0.00404105004411431,0.018955771271179,0.00251597526691759
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23523.Concentration of IDL Particles,39757,0.0206908855712687,0.00369858353040744,0.0134416618516701,0.0279401092908673,2.26768312921136e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23524.Total Lipids in IDL,39757,0.0229014443932167,0.00378239405703336,0.0154879520414313,0.0303149367450021,1.45162651272176e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23525.Phospholipids in IDL,39757,0.0224807558770903,0.00377844304872199,0.0150750075015952,0.0298865042525854,2.76632292558047e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23526.Cholesterol in IDL,39757,0.0220987703885021,0.00380146759344669,0.0146478939053466,0.0295496468716576,6.29613197517603e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39757,0.0222500378440511,0.00380714536303367,0.0147880329325051,0.0297120427555971,5.22988349507365e-09
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23528.Free Cholesterol in IDL,39757,0.0208176344751721,0.00377147918543936,0.013425535271711,0.0282097336786333,3.47064886137041e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23529.Triglycerides in IDL,39757,0.0144011618228867,0.00368184787091535,0.00718473999589258,0.0216175836498808,9.23084841103814e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39757,0.0175786473269037,0.00366001470698182,0.0104050185012193,0.0247522761525881,1.58426166694698e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23531.Total Lipids in Large LDL,39757,0.0181920550803385,0.00368022141500207,0.0109788211069344,0.0254052890537426,7.79697529347223e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23532.Phospholipids in Large LDL,39757,0.0180394444398911,0.00369149355784345,0.010804117066518,0.0252747718132643,1.03934462801089e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23533.Cholesterol in Large LDL,39757,0.0176363459162621,0.00368110549422999,0.0104213791475713,0.0248513126849528,1.68051599707878e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39757,0.0175950266439061,0.00367455284824746,0.0103929030613411,0.0247971502264711,1.70324204285092e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39757,0.0173026884478781,0.00371368982900258,0.010023856383033,0.0245815205127231,3.21169408297728e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23536.Triglycerides in Large LDL,39757,0.0143189977020732,0.00364620761022766,0.00717243078602699,0.0214655646181194,8.64960858109209e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39757,0.0156417208101692,0.00369251485640605,0.00840439169161331,0.022879049928725,2.29300348925564e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39757,0.0156363828008237,0.00367218107613514,0.00843890789159884,0.0228338577100486,2.07893136430837e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39757,0.0151820139228649,0.00368693321613794,0.00795562481923456,0.0224084030264953,3.85280745178707e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39757,0.0154384681311696,0.00366599090098967,0.00825312596522984,0.0226238102971093,2.55935253145529e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39757,0.015657321264238,0.00367834280631569,0.00844776936385924,0.0228668731646167,2.09234326426926e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39757,0.0138568066701755,0.00365053021380879,0.00670176745111023,0.0210118458892407,0.000147926778180947
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39757,0.011637347056057,0.00366948521353063,0.00444515603753698,0.018829538074577,0.0015212515202464
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39757,0.0161478696090447,0.00369617486386493,0.0089033668758694,0.0233923723422199,1.2605636932173e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23545.Total Lipids in Small LDL,39757,0.0159778630303323,0.00364782442789252,0.00882812715166291,0.0231275989090016,1.19702963111372e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23546.Phospholipids in Small LDL,39757,0.015700565875139,0.00363832369487164,0.00856945143319056,0.0228316803170874,1.60738214634068e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23547.Cholesterol in Small LDL,39757,0.0156122268414581,0.00365686811107325,0.00844476534375453,0.0227796883391617,1.9771892286101e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39757,0.0160364868257295,0.0036589628150101,0.0088649197083097,0.0232080539431493,1.18237343506401e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39757,0.0128153486691859,0.00365428490752041,0.00565295025044594,0.0199777470879259,0.000455078036573753
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23550.Triglycerides in Small LDL,39757,0.010237217989334,0.00370859029639948,0.00296838100839104,0.017506054970277,0.00578236848057454
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39757,0.0208841777600359,0.00422242396449546,0.0126082267896248,0.029160128730447,7.68515239774358e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39757,0.0190467856512865,0.00423485108245722,0.0107464775296704,0.0273470937729027,6.94096501198573e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39757,0.0178560682599845,0.00421050534111996,0.00960347779138943,0.0261086587285797,2.24482828849979e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39757,0.0184948841440759,0.0042929945138911,0.0100806148968494,0.0269091533913025,1.66031852599595e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39757,0.0187109160024174,0.00431859757924976,0.0102464647470878,0.0271753672577469,1.48623053753119e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39757,0.0163643194626607,0.00416531115926004,0.00820030959051103,0.0245283293348104,8.59158616006046e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39757,0.013092011735708,0.0035349563496647,0.00616349729036524,0.0200205261810509,0.000213599346097446
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39757,0.0176946271832965,0.00427682841267022,0.00931204349446288,0.0260772108721301,3.53957021506378e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23559.Total Lipids in Large HDL,39757,0.0165033491613261,0.00423929510265507,0.00819433076012212,0.02481236756253,9.96106518063767e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23560.Phospholipids in Large HDL,39757,0.0154905836148819,0.00419584630829403,0.00726672485062557,0.0237144423791382,0.000223658984918046
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23561.Cholesterol in Large HDL,39757,0.0161616118855622,0.00430794908547289,0.00771803167803536,0.0246051920930891,0.000176614133615984
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39757,0.0151321052247136,0.00432413927477466,0.0066567922461553,0.023607418203272,0.000468039261404552
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39757,0.0188638165863226,0.00425068702345553,0.0105324700203498,0.0271951631522955,9.17430072087152e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23564.Triglycerides in Large HDL,39757,0.0131407066182139,0.00372129909396673,0.00584696039403913,0.0204344528423887,0.000415324602706369
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39757,0.0124397440420662,0.00392834818514141,0.00474018159918903,0.0201393064849434,0.0015461556067185
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39757,0.0122191718861144,0.00386182539997815,0.00464999410215723,0.0197883496700716,0.00155985100864188
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39757,0.0124729394448933,0.00379468726564066,0.00503535240423765,0.019910526485549,0.00101592520983487
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39757,0.0105042456729241,0.00397387917327583,0.00271544249330351,0.0182930488525448,0.00822114630299517
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39757,0.00927452060730774,0.00396645603259572,0.00150026678342014,0.0170487744311953,0.019392444779818
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39757,0.0152426599150502,0.00399542013707017,0.00741163644639268,0.0230736833837077,0.000136899255791961
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39757,0.011518743811284,0.00382597608268031,0.00401983068923061,0.0190176569333374,0.00261256840633592
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39757,0.00928534091953096,0.00367435590573937,0.0020836033442818,0.0164870784947801,0.0115156801194369
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23573.Total Lipids in Small HDL,39757,0.0110171902451356,0.00367626687838013,0.00381170716351051,0.0182226733267606,0.0027339232544957
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23574.Phospholipids in Small HDL,39757,0.0114797839096172,0.00365836530709636,0.00430938790770832,0.018650179911526,0.00170574277182011
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23575.Cholesterol in Small HDL,39757,0.0087422086896161,0.00365544818275985,0.00157753025140679,0.0159068871278254,0.0167935891530855
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39757,0.00616790458831299,0.00366976395541825,-0.00102483276430679,0.0133606419409328,0.0928421862757701
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39757,0.0151104587678402,0.00365366487413127,0.00794927561454292,0.0222716419211375,3.56468056311841e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23578.Triglycerides in Small HDL,39757,0.00762076548358835,0.0041132950797965,-0.000441292872812788,0.0156828238399895,0.0639495391004563
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.0125185454112676,0.00413795818378958,-0.0206289434514952,-0.00440814737104008,0.00248973343059395
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.00284337327226067,0.00397824407769364,-0.0106407316645402,0.00495398512001886,0.47479085851799
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.00277387638103598,0.00402770749665211,-0.0106681830744741,0.00512043031240216,0.491027734818858
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,-0.00542888388354905,0.00396145932785481,-0.0131933441661445,0.00233557639904637,0.170582606977766
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39427,0.00579825203471762,0.00402850890771131,-0.00209762542439655,0.0136941294938318,0.150093104971843
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39696,0.00997412219232371,0.0040363444196642,0.00206288712978187,0.0178853572548655,0.0134855471815789
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39696,0.00198041986285438,0.00409417375369925,-0.00604416069439615,0.0100050004201049,0.628596546588155
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39696,0.000957425251398755,0.00407289950481794,-0.0070254577780444,0.00894030828084191,0.814157070419602
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39696,0.0067663989459308,0.00409407559201762,-0.00125798921442374,0.0147907871062853,0.0984142471524438
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39696,-0.00425119048020996,0.0040820946720956,-0.0122520960375173,0.00374971507709741,0.297701598939687
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39757,0.00297562281130027,0.00423223426385397,-0.00531955634585351,0.0112708019684541,0.482017098727159
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39757,0.00533246413005558,0.00394557406710987,-0.00240086104147978,0.0130657893015909,0.176561035062038
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39757,0.00586028643128951,0.00400885702522087,-0.00199707333814339,0.0137176462007224,0.143814668323951
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39757,0.00214447814699984,0.00400739001691577,-0.00571000628615507,0.00999896258015474,0.59257002302372
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39757,-0.00493345406195368,0.0040280319685059,-0.0128283967202252,0.00296148859631788,0.220683880606083
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39757,0.0125250775878797,0.00388260338840627,0.00491517494660339,0.020134980229156,0.00125918069371745
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39757,0.00889835339792552,0.00401935768819249,0.00102041232906824,0.0167762944667828,0.0268575606153909
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39757,0.00785331530223374,0.00404251010492582,-7.00045034208695e-05,0.0157766351078884,0.0520796076334908
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39757,0.011642224155251,0.00393233692769586,0.00393484377696713,0.0193496045335349,0.0030764910512934
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39757,-0.00981528744919471,0.00398477181635146,-0.0176254402092436,-0.00200513468914585,0.0137853172845748
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39757,0.00887540850845279,0.00392713672443198,0.00117822052856612,0.0165725964883395,0.0238391920623929
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39757,0.00713177216013476,0.00379256416743697,-0.0003016536080417,0.0145651979283112,0.0600711908940748
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39757,0.00528210919263469,0.00373091426517794,-0.00203048276711408,0.0125947011523835,0.15687134267834
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39757,0.00921042643614644,0.00396127473348651,0.00144632795851288,0.01697452491378,0.0200835599037842
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39757,-0.00765563286542321,0.00383097153904677,-0.0151643370819549,-0.000146928648891548,0.0457026452270463
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39757,-0.00651233711061263,0.00371309269728082,-0.013789998797283,0.000765324576057774,0.0794776906316594
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39757,0.0114170919444088,0.00391154089170381,0.00375047179666934,0.0190837120921483,0.00352058772152873
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39757,0.011697673930362,0.00396202287848575,0.00393210908852998,0.0194632387721941,0.00315920030837171
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39757,0.00680725746112088,0.00346350608854235,1.87855275778758e-05,0.0135957293946639,0.0493899691787347
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39757,-0.0107160528812358,0.00386178575884386,-0.0182851529685697,-0.00314695279390181,0.00553112869117186
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39757,-0.00929246373555437,0.00363610027717604,-0.0164192202788194,-0.00216570719228933,0.0106132448566172
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39757,0.00966362256817946,0.00380379841532026,0.00220817767415174,0.0171190674622072,0.0110822395866485
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39757,0.0101038955657339,0.00376050086268346,0.00273331387487433,0.0174744772565935,0.00722365782496476
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39757,0.00202279675963658,0.00349789519388243,-0.00483307782037298,0.00887867133964615,0.563080219714207
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39757,-0.00785824562370522,0.0038286640381117,-0.0153624271384041,-0.000354064109006291,0.0401465861270549
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39757,-0.00751728366782843,0.00370552477431493,-0.0147801122254857,-0.000254455110171164,0.0425157055413174
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39757,0.00706730570925472,0.0037821471161285,-0.000345702638357142,0.0144803140568666,0.0617052010025999
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39757,0.00537624530001848,0.00359692347930387,-0.0016737247194171,0.0124262153194541,0.135026568855588
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39757,0.00543980082479434,0.00405523243837344,-0.0025084547544176,0.0133880564040063,0.179808956443058
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39757,-0.00499987741121207,0.00372281993381862,-0.0122966044814966,0.00229684965907243,0.179287965410375
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39757,-0.0101016506904663,0.00380079408371186,-0.0175512070945416,-0.0026520942863911,0.00787707933560087
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39757,0.00957181840943621,0.00375777714386632,0.00220657520745822,0.0169370616114142,0.0108723514903129
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39757,0.00958194650253782,0.00379738741763533,0.00213906716397257,0.0170248258411031,0.0116397029105204
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39757,-0.0019582507601735,0.00391272041020683,-0.00962718276417889,0.00571068124383189,0.616744767416642
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39757,-0.00476734238327773,0.00371207371643903,-0.0120430068674982,0.00250832210094277,0.199070635745687
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39757,-0.00646556789852605,0.00379406411313056,-0.0139019335602619,0.000970797763209836,0.0883851685477461
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39757,0.00585592305239986,0.00368761000339476,-0.00137179255425387,0.0130836386590536,0.112314775722132
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39757,0.00888858896654799,0.00375865528922034,0.00152162459967611,0.0162555533334199,0.018055259203708
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39757,-0.00243212400660597,0.00372258710229019,-0.00972839472709474,0.00486414671388279,0.51354902442726
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39757,-0.00169995030425584,0.00379486314179517,-0.00913788206217436,0.00573798145366269,0.654190114097893
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39746,0.011192075107381,0.00401444122318115,0.00332377030994593,0.019060379904816,0.0053132024855259
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39746,-0.0104498764634506,0.00348981049065304,-0.0172899050251306,-0.00360984790177068,0.00275592010048971
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39746,-0.00135706339614994,0.00325965760598856,-0.00774599230388751,0.00503186551158763,0.67718326025851
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39746,-0.0178667341279871,0.00416523541057807,-0.0260305955327201,-0.00970287272325404,1.80593799675921e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39746,-0.00372043094462458,0.00395162630843732,-0.0114656185091617,0.00402475661991255,0.346472363362311
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39757,-0.00830176511594331,0.00373364319959028,-0.0156197057871402,-0.000983824444746366,0.0262018817846735
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39757,0.00502731918825471,0.00394484710880959,-0.00270458114501209,0.0127592195215215,0.202547693028548
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39757,0.00102363571619362,0.00379856035818565,-0.00642154258585025,0.0084688140182375,0.787565380960666
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39757,0.0180531563529413,0.0037494951406015,0.0107041458773623,0.0254021668285202,1.49265057587315e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39757,-0.00271567416109411,0.00379367497075181,-0.0101512771037677,0.00471992878157945,0.474103524796305
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39757,0.000416232136007444,0.00404311406938068,-0.00750827143997869,0.00834073571199357,0.918005772052261
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39757,-0.00306240012414842,0.00402740875029323,-0.0109561212747232,0.00483132102642631,0.447037747528809
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39757,-0.00773327421768654,0.00382262885247981,-0.015225626768547,-0.000240921666826111,0.0430943579423085
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39757,0.019600767108579,0.0042178429145477,0.0113337949960655,0.0278677392210924,3.40477804650522e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39757,0.00480184476371785,0.00396387587720439,-0.00296735195560275,0.0125710414830385,0.225767262242266
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39757,0.00482332465326621,0.00366623694268042,-0.0023624997543874,0.0120091490609198,0.188333229774489
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39757,-0.00516445359011587,0.0036425516252937,-0.0123038547756915,0.00197494759545978,0.156273572196096
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39757,-0.00846635126644282,0.00358447771038709,-0.0154919275788015,-0.00144077495408412,0.0181962504369417
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39757,0.0158866120209882,0.00390037664296429,0.00824187380077817,0.0235313502411982,4.67128152796611e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39757,0.00259427471222713,0.0041192068116985,-0.00547937063870193,0.0106679200631562,0.528838618579081
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48486,0.00550101666243416,0.00308682373629453,-0.000549157860703119,0.0115511911855714,0.0747488092368856
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48486,0.00560195779321209,0.00300794865277591,-0.000293621566228694,0.0114975371526529,0.062563609314578
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47094,0.00452144888804818,0.00287761244426994,-0.0011186715027209,0.0101615692788173,0.116141670199313
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47094,0.00354938415039591,0.00313338623358618,-0.00259205286743301,0.00969082116822482,0.257328457062127
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47094,0.00426604817519732,0.00309063984906978,-0.00179160592897945,0.0103237022793741,0.167507195140487
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47094,0.00185305581992976,0.00285419364217566,-0.00374116371873454,0.00744727535859406,0.516191518139226
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24009.Traffic intensity on the nearest road,48486,-0.0100681486309958,0.0753819289709397,-0.157816729414038,0.137680432152046,0.893750417895424
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24010.Inverse distance to the nearest road,48486,-0.0013135134594013,0.00270682538224845,-0.00661889120860825,0.00399186428980566,0.627497435334384
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24011.Traffic intensity on the nearest major road,48486,0.00130908441362452,0.00268807514554965,-0.00395954287165279,0.00657771169890184,0.626265855696185
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24012.Inverse distance to the nearest major road,48486,0.00244422779254688,0.00274501558329113,-0.00293600275070373,0.00782445833579749,0.373249025172252
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24013.Total traffic load on major roads,48486,0.0117312850912369,0.0527809877790526,-0.091719450955706,0.11518202113818,0.824111076148745
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24015.Sum of road length of major roads within 100m,48486,0.00466871404751634,0.0514123289247436,-0.096099450644981,0.105436878740014,0.927645089832262
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48486,0.00541197084252321,0.0031052243143876,-0.000674268813676482,0.0114982104987229,0.0813735521426712
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48486,0.00563683319076475,0.00310474786136498,-0.000448472617510613,0.0117221389990401,0.0694540778501439
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48486,0.0045987851448395,0.00306696539398336,-0.00141246702736789,0.0106100373170469,0.133770786221906
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48447,0.00175511395966893,0.00299023147249516,-0.00410573972642158,0.00761596764575945,0.557244503833283
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24020.Average daytime sound level of noise pollution,48486,0.000796453728505961,0.0026941230474823,-0.00448402744455934,0.00607693490157126,0.76751854460887
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24021.Average evening sound level of noise pollution,48486,0.000802500600141389,0.00269454566438672,-0.00447880890205657,0.00608381010233935,0.765840541451741
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24022.Average night-time sound level of noise pollution,48486,0.000789890515475663,0.00269413186546359,-0.00449060794083298,0.00607038897178431,0.769380555723478
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48486,0.000798516212323497,0.00269446008761883,-0.00448262555940942,0.00607965798405641,0.76696222577602
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48486,0.000779008912969351,0.00269455605563026,-0.00450232095606595,0.00606033878200465,0.772504244329484
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2405.Number of children fathered,48471,0.00613374685179536,0.0397364527536139,-0.071749700545288,0.0840171942488787,0.877326903037841
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46211,-0.0035153699808754,0.00320957625835273,-0.00980613944724674,0.00277539948549595,0.27341097157106
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46211,0.00477933094053698,0.00288419842426716,-0.000873697971026646,0.0104323598521006,0.0975222770815656
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24502.Water percentage, buffer 1000m",46211,-0.00510183334334331,0.00290923587364052,-0.0108039356556787,0.000600268968992113,0.0795048362215582
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46211,-0.00319159963540325,0.00300901325585088,-0.00908926561687098,0.00270606634606448,0.288849980367431
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46211,0.00467698863275234,0.00291540334147834,-0.00103720191654521,0.0103911791820499,0.108680454693374
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24505.Water percentage, buffer 300m",46211,-0.00596460045084896,0.00292231136490211,-0.0116923307260571,-0.000236870175640823,0.0412601611360933
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48551,-0.00419039834950621,0.00306116538234997,-0.0101902824989121,0.00180948579989973,0.171049107214354
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48551,-0.00411855125520274,0.0028712622053649,-0.00974622517771796,0.00150912266731247,0.151472554936813
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24508.Distance (Euclidean) to coast,48551,0.00413190703099769,0.00271487787464693,-0.00118925360331029,0.00945306766530566,0.128037582470196
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2867.Age started smoking in former smokers,34495,0.00748273813778287,0.00499887888701026,-0.00231506448075723,0.017280540756323,0.1344771725243
CCND2,G1/S-specific cyclin-D2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35613,0.091197621558642,0.0784904799942896,-0.0626437192301656,0.24503896234745,0.245318057042158
CCND2,G1/S-specific cyclin-D2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35614,0.174277294278806,0.0906481509006877,-0.00339308148654163,0.351947670044154,0.0545747055961493
CCND2,G1/S-specific cyclin-D2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35614,0.0584602877742646,0.0832099727131502,-0.10463125874351,0.221551834292039,0.482351151771249
CCND2,G1/S-specific cyclin-D2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35605,0.0492665079470109,0.0833785143982019,-0.114155380273465,0.212688396167487,0.554621412379275
CCND2,G1/S-specific cyclin-D2,Mental health,X28739.Difficulty with standing for long periods,35617,0.0309238094466351,0.0704883545379911,-0.107233365447828,0.169080984341098,0.660886596771961
CCND2,G1/S-specific cyclin-D2,Mental health,X28740.Difficulty with taking care of household responsibilities,35633,0.0256457812894613,0.0817317561123504,-0.134548460690745,0.185840023269668,0.753697530345558
CCND2,G1/S-specific cyclin-D2,Mental health,X28741.Difficulty learning a new task,35596,0.0416871340731705,0.0965314113064718,-0.147514432087514,0.230888700233855,0.665863418742408
CCND2,G1/S-specific cyclin-D2,Mental health,X28742.Difficulty with joining in community activities,35232,-0.00816406591715521,0.0878364652331366,-0.180323537774103,0.163995405939793,0.92594910876865
CCND2,G1/S-specific cyclin-D2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35592,0.089804671705345,0.0784551987062893,-0.0639675177589821,0.243576861169672,0.252388465168391
CCND2,G1/S-specific cyclin-D2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35641,-0.00127330876780914,0.104851802048739,-0.206782840783338,0.20423622324772,0.990311159881097
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,33989,-0.108376334155168,0.0746037323723546,-0.254599649604983,0.0378469812946475,0.146367190182012
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2897.Age stopped smoking,34484,0.00651431418316447,0.00528062270917288,-0.00383570632681438,0.0168643346931433,0.217391524570823
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34797,-0.00663355552407898,0.0111439656015365,-0.0284757281030904,0.0152086170549325,0.551691511392886
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34797,0.00718592420062554,0.0125145268506695,-0.0173425484266867,0.0317143968279378,0.565848829033777
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34797,0.00275663221116597,0.0421060192060171,-0.0797711654326275,0.0852844298549595,0.947802827402836
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34797,-0.0545691755878666,0.0433183674840402,-0.139473175856585,0.0303348246808521,0.207816480734008
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34797,0.0246155734386501,0.0506823001411091,-0.0747217348379238,0.123952881715224,0.627208524027697
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34797,0.103759129047489,0.0473285171475215,0.0109952354383466,0.196523022656631,0.0283936602143788
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34797,-0.00519887291256521,0.0190166042987844,-0.0424714173381827,0.0320736715130523,0.784565642862054
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34797,0.0393928930444675,0.0366595376562521,-0.0324598007617865,0.111245586850722,0.28261335768746
CCND2,G1/S-specific cyclin-D2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34770,0.1225686537348,0.0853206193937151,-0.044659760276882,0.289797067746481,0.150892225631619
CCND2,G1/S-specific cyclin-D2,Mental health,X29003.Recent feelings of depression,34771,0.114077350113884,0.084276341897862,-0.0511042800059253,0.279258980233694,0.175910232983414
CCND2,G1/S-specific cyclin-D2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34773,0.173203433863182,0.0663166112185475,0.0432228758748288,0.303183991851535,0.0090294166150446
CCND2,G1/S-specific cyclin-D2,Mental health,X29005.Recent feelings of tiredness or low energy,34775,0.0935122742045077,0.0646363581601536,-0.0331749877893934,0.220199536198409,0.148019363595334
CCND2,G1/S-specific cyclin-D2,Mental health,X29006.Recent poor appetite or overeating,34781,0.136592241012118,0.104431832049019,-0.06809414980396,0.341278631828196,0.190936891220181
CCND2,G1/S-specific cyclin-D2,Mental health,X29007.Recent feelings of inadequacy,34763,-0.00622919248223842,0.0909538694662026,-0.184498776635995,0.172040391671519,0.945399886012359
CCND2,G1/S-specific cyclin-D2,Mental health,X29008.Recent trouble concentrating on things,34779,0.18206928508313,0.0891056098468497,0.00742228978330459,0.356716280382955,0.0410653235319776
CCND2,G1/S-specific cyclin-D2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34774,0.167342220400843,0.152750926244503,-0.132049595038382,0.466734035840068,0.273330127974864
CCND2,G1/S-specific cyclin-D2,Mental health,X29010.Recent thoughts of suicide or self-harm,34758,0.128730688380378,0.165909294755181,-0.196451529339777,0.453912906100533,0.437831908227046
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#0.Substances taken for depression_None of options listed,34869,-0.00696314157909155,0.0214490481774047,-0.0490032760068047,0.0350769928486216,0.745467113849539
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34869,0.0242015534405857,0.038846572987401,-0.0519377296147202,0.100340836495892,0.533304842027119
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34869,-0.0143776439197525,0.0245077365858666,-0.0624128076280511,0.0336575197885461,0.557454977954583
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34869,-0.0536489961135043,0.0724204154042407,-0.195593010305816,0.0882950180788076,0.458842859419185
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34869,-0.00206081856832861,0.0483578918409862,-0.0968422865766615,0.0927206494400043,0.966009020367205
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34869,-0.0568291803039276,0.0567853331965824,-0.168128433369229,0.054470072761374,0.316975600309077
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34869,-0.0358450530497446,0.0580102035894,-0.149545052084968,0.0778549459854794,0.536657474472187
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34869,0.0111901868241782,0.0680535150103253,-0.122194702596059,0.144575076244416,0.869396245199916
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34869,0.0164713590019358,0.0475395263950788,-0.0767061127324186,0.10964883073629,0.728995791679467
CCND2,G1/S-specific cyclin-D2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34869,-0.00831849856074724,0.0204051013609791,-0.0483124972282663,0.0316755001067719,0.683531653100776
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34869,-0.0438864675429607,0.032805893647218,-0.108186019091508,0.0204130840055866,0.181022662111083
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34869,-0.0246791541200555,0.0536037905120741,-0.129742583523721,0.0803842752836097,0.64524551882249
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34869,0.0455100565915561,0.0636234719678543,-0.0791919484654383,0.170212061648551,0.474448510223767
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34869,-0.0139297643365223,0.0405792427611196,-0.0934650801483167,0.0656055514752721,0.731404491681024
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34869,-0.0224594913888507,0.0599313181297711,-0.139924874923202,0.0950058921455006,0.7078562258492
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34869,0.0237656483899993,0.0580496836715981,-0.0900117316063331,0.137543028386332,0.68225876283468
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34869,-0.0441390810406959,0.032610469593009,-0.108055601442994,0.0197774393616017,0.175936814675935
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34869,-0.035965798563504,0.032410333807271,-0.0994900528257552,0.0275584556987471,0.267170207627846
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34869,-0.0664012665903628,0.0486540164520209,-0.161763138836324,0.0289606056555982,0.172376111284155
CCND2,G1/S-specific cyclin-D2,Mental health,X29058.Recent feelings or nervousness or anxiety,34678,0.111918741181469,0.0819428479076394,-0.048689240717504,0.272526723080443,0.172047704179038
CCND2,G1/S-specific cyclin-D2,Mental health,X29059.Recent inability to stop or control worrying,34682,0.116405567131771,0.0869803930434977,-0.054076003233484,0.286887137497027,0.180849803655275
CCND2,G1/S-specific cyclin-D2,Mental health,X29060.Recent worrying too much about different things,34682,0.108136548063034,0.0777144766746751,-0.0441838262193292,0.260456922345397,0.164137034966799
CCND2,G1/S-specific cyclin-D2,Mental health,X29061.Recent trouble relaxing,34678,0.139437918726758,0.0833262826500628,-0.0238815952673647,0.302757432720881,0.0943007208132014
CCND2,G1/S-specific cyclin-D2,Mental health,X29062.Recent restlessness,34686,0.0950452790481134,0.114760362253336,-0.129885030968425,0.319975589064652,0.407586044671424
CCND2,G1/S-specific cyclin-D2,Mental health,X29063.Recent easy annoyance or irritability,34676,0.055027719388026,0.0793177266210122,-0.100435024789158,0.21049046356521,0.487857257664162
CCND2,G1/S-specific cyclin-D2,Mental health,X29064.Recent feelings of foreboding,34680,0.240637711931655,0.101046514409041,0.0425865436899352,0.438688880173375,0.017275009373322
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34869,0.00289788528568624,0.0254643022956414,-0.0470121472137708,0.0528079177851433,0.909398498289161
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34869,-0.0260666039000109,0.0384957979398253,-0.101518367862068,0.0493851600620468,0.498349380353538
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34869,-0.000679388674701869,0.0536572399467204,-0.105847578970274,0.10448880162087,0.989898145474318
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34869,0.00859972972143057,0.0522525181819047,-0.0938152059151026,0.111014665357964,0.869279725476564
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#2.Symptoms of panic attack_Sweating,34869,-0.024708577811237,0.0333285517154331,-0.0900325391734858,0.0406153835510118,0.458500729030459
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34869,0.0101296367145753,0.0414274293483575,-0.0710681248082053,0.091327398237356,0.806839823454637
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34869,0.00296722653749699,0.0392443955406872,-0.0739517887222499,0.0798862417972439,0.939732648680564
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34869,-0.03959635438341,0.0408328374626496,-0.119628715810203,0.0404360070433832,0.332224280060665
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34869,-0.0250500151196318,0.049036967012845,-0.121162470464808,0.0710624402255444,0.609481501521347
CCND2,G1/S-specific cyclin-D2,Mental health,X29076.Felt loved as a child,34654,-0.0160845910380265,0.0639144559781012,-0.141356924755105,0.109187742679052,0.801313886445758
CCND2,G1/S-specific cyclin-D2,Mental health,X29077.Physically abused by family as a child,34663,0.0642047854397679,0.0844882881113133,-0.101392259258406,0.229801830137942,0.447328815331753
CCND2,G1/S-specific cyclin-D2,Mental health,X29078.Felt hated by family member as a child,34656,0.0446526128945314,0.0964450184471108,-0.144379623261806,0.233684849050869,0.643391644098545
CCND2,G1/S-specific cyclin-D2,Mental health,X29079.Sexually molested as a child,34642,-0.0879816966398061,0.136904695705225,-0.356314900222048,0.180351506942435,0.520476131304462
CCND2,G1/S-specific cyclin-D2,Mental health,X29080.Someone to take to doctor when needed as a child,34651,0.103066231474219,0.095356973127992,-0.0838334358566453,0.289965898805083,0.279808585990334
CCND2,G1/S-specific cyclin-D2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34660,0.0800961215835483,0.14972511396117,-0.213365101780346,0.373557344947442,0.592700960299708
CCND2,G1/S-specific cyclin-D2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34645,0.0556778745886626,0.126345136859646,-0.191958593656244,0.303314342833569,0.659459867088361
CCND2,G1/S-specific cyclin-D2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34670,-0.238629881160186,0.130168605811604,-0.49376034855093,0.0165005862305575,0.0668163127293199
CCND2,G1/S-specific cyclin-D2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34663,0.272403190341694,0.44831714041819,-0.606298404877958,1.15110478556135,0.543467132553463
CCND2,G1/S-specific cyclin-D2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34656,0.50914943177228,0.275822180943258,-0.0314620428765053,1.04976090642106,0.0649506291430051
CCND2,G1/S-specific cyclin-D2,Mental health,X29086.Experienced a violent or sexual assault,34675,-0.0830286216183601,0.148277022766845,-0.373651586241376,0.207594343004656,0.575530039441429
CCND2,G1/S-specific cyclin-D2,Mental health,X29087.Experienced a life-threatening injury or illness,34667,0.0295337404672367,0.0743631571545689,-0.116218047555718,0.175285528490192,0.691266732227568
CCND2,G1/S-specific cyclin-D2,Mental health,X29088.Experienced a marital separation or divorce,34667,-0.122193195297136,0.0734763726849591,-0.266206885759656,0.0218204951653842,0.0963586813287128
CCND2,G1/S-specific cyclin-D2,Mental health,X29089.Experienced the death of a spouse or partner,34678,0.0152877855031295,0.110274616973993,-0.200850463765896,0.231426034772155,0.889744152634803
CCND2,G1/S-specific cyclin-D2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34668,-0.177759761867754,0.0890176242250514,-0.352234305348855,-0.00328521838665319,0.0458800711298401
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29091.Frequency of drinking alcohol,34664,0.00570850550302329,0.0601225250172808,-0.112131643530847,0.123548654536894,0.924359374656124
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34164,-0.0208404389676611,0.0637526422551174,-0.145795617787691,0.104114739852369,0.743759380865548
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34181,0.0340086160925526,0.0637824258790995,-0.0910049386304824,0.159022170815588,0.593918265728842
CCND2,G1/S-specific cyclin-D2,Mental health,X29104.Ever used cannabis,34660,-0.10689361191267,0.0795336718598608,-0.262779608757997,0.0489923849326567,0.178997274492503
CCND2,G1/S-specific cyclin-D2,Mental health,X29108.Ever thought that life not worth living,34638,-0.0388057025214182,0.0806093679736269,-0.196800063749727,0.119188658706891,0.630246575322777
CCND2,G1/S-specific cyclin-D2,Mental health,X29109.Ever contemplated self-harm,34642,-0.0314461128190189,0.114554686631689,-0.25597329861713,0.193081072979092,0.783704079727281
CCND2,G1/S-specific cyclin-D2,Mental health,X29111.Ever self-harmed,34654,0.0578832211852346,0.209154306541563,-0.352059219636229,0.467825662006698,0.781982381674461
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34656,-0.0235385978875012,0.123592448316616,-0.265779796588068,0.218702600813066,0.848960266974031
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35330,-0.107805743173015,0.0531090267688128,-0.211899435639888,-0.00371205070614146,0.0424064810622615
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35330,-0.0324317562335137,0.0410206828385463,-0.112832294597065,0.0479687821300371,0.429193859073163
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35330,-0.0477832467151725,0.0489878785504246,-0.143799488674005,0.0482329952436597,0.32939218482213
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35330,-0.0324550779040276,0.0856517136903847,-0.200332436737182,0.135422280929126,0.704759827413674
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34643,-0.0334199168159842,0.0692961413268646,-0.169240353816639,0.10240052018467,0.629626841880053
CCND2,G1/S-specific cyclin-D2,Health and medical history,X29153.Pain or discomfort today,34656,-0.0489726874959079,0.0635081248793915,-0.173448612259515,0.0755032372676995,0.440663085743066
CCND2,G1/S-specific cyclin-D2,Mental health,X29154.Anxiety or depression today,34656,0.0471024547786031,0.0854436903808781,-0.120367178367918,0.214572087925124,0.581469657485639
CCND2,G1/S-specific cyclin-D2,Mental health,X29166.Frequency of confiding in someone close,34501,-0.00836807415421203,0.0626380359191386,-0.131138624555724,0.1144024762473,0.893728081750289
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34642,0.024109010686272,0.0105139109916852,0.00350174514256898,0.0447162762299751,0.0218788377727222
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34642,-0.0108464849766756,0.0108823731390723,-0.0321759363292573,0.0104829663759062,0.318949007845828
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34642,-0.013487577978094,0.0115508028572214,-0.0361271515782479,0.00915199562205987,0.242984161914184
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34642,-0.0013801891352623,0.0159602680545119,-0.0326623145221056,0.029901936251581,0.931090451319026
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34642,-0.0391646067860413,0.0317812050341921,-0.101455768653058,0.0231265550809752,0.217877614852219
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34642,-0.00351099499353434,0.0116906418631746,-0.0264246530453566,0.0194026630582879,0.76393940385373
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34636,0.00965527434503076,0.0122357805391387,-0.0143268555116812,0.0336374042017427,0.430083603783644
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34636,-0.0015020698819194,0.0193649331806027,-0.0394573389159006,0.0364531991520618,0.938175470678054
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34636,-0.00883266684810013,0.0217616648110564,-0.0514855298777707,0.0338201961815705,0.684843731688763
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34636,0.0114446794028307,0.0270223328925439,-0.0415190930665553,0.0644084518722167,0.67192611484923
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34636,0.0761056024318076,0.0456962304692978,-0.013459009288016,0.165670214151631,0.0958713481140164
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34636,-0.0108919379681261,0.0174772052619878,-0.0451472602816222,0.0233633843453699,0.533171247645829
CCND2,G1/S-specific cyclin-D2,Mental health,X29171.Frequency of feeling 'in tune' with people,34487,0.133131190577444,0.0770088993884482,-0.0178062522239146,0.284068633378803,0.0839015065710278
CCND2,G1/S-specific cyclin-D2,Mental health,X29172.Freuency of feeling that lacks companionship,34602,-0.0109247986187014,0.0728407510421698,-0.153692670661354,0.131843073423951,0.880783888362646
CCND2,G1/S-specific cyclin-D2,Mental health,X29173.Frequency of feeling left out,34574,-0.0511268347218877,0.0752082067711864,-0.198534919993413,0.0962812505496377,0.496654961050463
CCND2,G1/S-specific cyclin-D2,Mental health,X29174.Frequency of feeling isolated from others,34604,-0.100235597625538,0.0764806099721233,-0.2501375931709,0.0496663979198237,0.190042590834465
CCND2,G1/S-specific cyclin-D2,Mental health,X29175.Tendency to bounce back quickly after hard times,34649,-0.0930147046624854,0.0624359183489526,-0.215389104626433,0.0293596953014618,0.136338793800769
CCND2,G1/S-specific cyclin-D2,Mental health,X29176.Ability to make it through stressful events,34649,0.0845937120129498,0.0601444311929324,-0.0332893731251977,0.202476797151097,0.159624290242424
CCND2,G1/S-specific cyclin-D2,Mental health,X29177.Quick recovery from stressful events,34649,-0.058861378607417,0.0617723134203328,-0.179935112911269,0.0622123556964354,0.340690799679472
CCND2,G1/S-specific cyclin-D2,Mental health,X29178.Hard to snap back when something bad happens,34649,0.0275106835692507,0.0625580520580251,-0.0951030984644785,0.15012446560298,0.660124869593097
CCND2,G1/S-specific cyclin-D2,Mental health,X29179.Comes through difficult times with little trouble,34649,-0.0471974775498105,0.0614283690416619,-0.167597080871468,0.0732021257718468,0.442319049303082
CCND2,G1/S-specific cyclin-D2,Mental health,X29180.Tendency to take a long time to get over setbacks,34649,0.0621082574624649,0.0608434850635343,-0.0571449732620624,0.181361488186992,0.307396060818645
CCND2,G1/S-specific cyclin-D2,Mental health,X29181.General happiness,34615,0.126448764459432,0.0626985968946098,0.00355951454599637,0.249338014372867,0.0437637096795492
CCND2,G1/S-specific cyclin-D2,Mental health,X29182.Belief that own life is meaningful,34535,-0.0893644691989049,0.0639213022555913,-0.214650221619864,0.0359212832220541,0.162153645789895
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,33923,0.0207236208232118,0.0656014233289937,-0.107855168901616,0.14930241054804,0.75208928155357
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2946.Father's age,32819,-0.0107115917300456,0.00873396378398694,-0.02783016074666,0.00640697728656884,0.220105494237073
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2966.Age high blood pressure diagnosed,34443,-0.00833342216651463,0.00672732332405252,-0.0215189758816576,0.00485213154862831,0.215490587730009
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48166,0.0130012313933857,0.00289864243634929,0.00731989221814113,0.0186825705686304,7.32314795372692e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48167,-0.000507457355479057,0.00314469583348171,-0.00667106118910322,0.0056561464781451,0.871804213318369
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30020.Haemoglobin concentration,48167,-0.00484373818289686,0.00332944416770849,-0.0113694487516055,0.00168197238581177,0.14573545542606
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30030.Haematocrit percentage,48167,-0.00269169318991011,0.00326412884343583,-0.00908938572304434,0.00370599934322412,0.409592671883835
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30040.Mean corpuscular volume,48167,-0.00288216939021921,0.00287253393672234,-0.00851233590619499,0.00274799712575657,0.315702334106326
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48167,-0.00511019442660137,0.00287812840867534,-0.010751326107605,0.000530937254402288,0.0758264666128286
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48167,-0.00485054950782669,0.00280806066909627,-0.0103543484192554,0.000653249403602006,0.0841176702966404
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48167,0.00685848056523551,0.00292744654382302,0.00112068533934239,0.0125962757911286,0.0191485731237167
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30080.Platelet count,48167,0.000536392578583888,0.00287365810111071,-0.00509597729959311,0.00616876245676088,0.851930367504186
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30090.Platelet crit,48167,-0.000114633830790437,0.00292799459901352,-0.00585350324485694,0.00562423558327607,0.968770422760833
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48167,-0.000905181581559456,0.00271586156777828,-0.00622827025440489,0.00441790709128597,0.738915601178812
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30110.Platelet distribution width,48167,-0.00282366442852457,0.00279996759528272,-0.00831160091527869,0.00266427205822956,0.313244590761066
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30120.Lymphocyte count,48133,0.0155850395205894,0.00281176029673217,0.0100739893389943,0.0210960897021845,3.0151174860352e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30130.Monocyte count,48133,0.013225583105778,0.00283607531232587,0.00766687549361931,0.0187842907179367,3.13177010444325e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30140.Neutrophill count,48133,0.00454746240295477,0.00286818896879771,-0.00107418797588875,0.0101691127817983,0.112873017880632
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30150.Eosinophill count,48133,0.0109458506096601,0.0027186055788526,0.00561738367510901,0.0162743175442112,5.68816044648069e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30160.Basophill count,48133,0.0974982052154223,0.0383737135674661,0.0222857266231887,0.172710683807656,0.0110690104219394
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30170.Nucleated red blood cell count,48133,-0.162761201427386,0.194284481990716,-0.543558786129189,0.218036383274416,0.402183178653212
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30180.Lymphocyte percentage,48134,0.00711038332270948,0.00279142118813716,0.00163919779396065,0.0125815688514583,0.0108658761470202
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30190.Monocyte percentage,48134,0.00508902984735595,0.00280050980441556,-0.000399969369298541,0.0105780290640104,0.0692049020911287
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30200.Neutrophill percentage,48134,-0.00951362806949875,0.00275181543789495,-0.0149071863277728,-0.00412006981122465,0.000546943050198561
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30210.Eosinophill percentage,48134,0.00636773771215379,0.00269703291004569,0.00108155320846423,0.0116539222158433,0.0182347106171755
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30220.Basophill percentage,48134,0.00570929674651444,0.00283558572353497,0.000151548728385893,0.011267044764643,0.0440814928759576
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30230.Nucleated red blood cell percentage,48133,-0.161442159657734,0.194324670057561,-0.542318512970553,0.219434193655086,0.406104849820531
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30240.Reticulocyte percentage,47819,0.00479484936012099,0.00297701645086775,-0.0010401028835798,0.0106298016038218,0.107278472117014
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30250.Reticulocyte count,47819,0.00506238080963797,0.00300890736456776,-0.000835077624914833,0.0109598392441908,0.0924949838345991
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30260.Mean reticulocyte volume,47819,-0.00324283143889745,0.0028257844713256,-0.00878136900269562,0.00229570612490073,0.25115368849252
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30270.Mean sphered cell volume,47819,-0.00341845697048606,0.00283728464660232,-0.00897953487782661,0.00214262093685448,0.228282232680512
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30280.Immature reticulocyte fraction,47819,0.00622498862373871,0.00293207683369581,0.000478118029694926,0.0119718592177825,0.0337611803044759
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47819,0.0064182572195556,0.00301638712008008,0.000506138464198656,0.0123303759749126,0.0333666708003091
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30300.High light scatter reticulocyte count,47819,0.00659461898066746,0.00303138796478975,0.000653098569679542,0.0125361393916554,0.0296089012744754
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30500.Microalbumin in urine,35774,0.00722465701419126,0.00453216534799383,-0.00165838706787666,0.0161077010962592,0.110961039547011
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48204,-0.00229118852862709,0.00302923996821913,-0.0082284988663366,0.00364612180908241,0.449443939273478
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30520.Potassium in urine,48168,-0.00430119216785205,0.00282514821470531,-0.00983848266867445,0.00123609833297035,0.127908511542254
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30530.Sodium in urine,48173,0.00835345724415072,0.00292355023202717,0.00262329878937747,0.014083615698924,0.00427713465260604
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30600.Albumin,46321,0.00310427845942073,0.00299483795965917,-0.00276560394151125,0.00897416086035271,0.299963012070126
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30610.Alkaline phosphatase,47795,0.0105517280041935,0.0029592789704412,0.00475154122212879,0.0163519147862583,0.000363849404573916
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30620.Alanine aminotransferase,47780,0.0143304930046216,0.00319252383360098,0.00807314629076371,0.0205878397184796,7.20538467208217e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30630.Apolipoprotein A,46268,0.0115319801353646,0.00324274217906713,0.00517620546439304,0.0178877548063362,0.000377179387961731
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30640.Apolipoprotein B,47654,0.00978118532625358,0.00277129646391611,0.004349444256978,0.0152129263955292,0.000417387056934892
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30650.Aspartate aminotransferase,47727,0.0234647494402086,0.00293697139699837,0.0177082855020918,0.0292212133783254,1.43190260850078e-15
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30660.Direct bilirubin,46465,-0.00699886898699669,0.00301730703298179,-0.012912790771641,-0.00108494720235239,0.0203751127707378
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30670.Urea,47784,0.00932671477383022,0.0029263308387096,0.0035911063299594,0.015062323217701,0.00143902472576951
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30680.Calcium,46312,-0.0020929247850211,0.00297077862544289,-0.00791565089088916,0.00372980132084695,0.481128356755486
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30690.Cholesterol,47798,0.0145898318033709,0.00279250614860282,0.00911651975210935,0.0200631438546324,1.76320025835922e-07
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30700.Creatinine,47790,0.0112697366659925,0.00368489412860828,0.00404734417392029,0.0184921291580647,0.00222857773434854
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30710.C-reactive protein,47725,0.0105531804898785,0.00308752810151305,0.00450162541091293,0.0166047355688441,0.000632138207882765
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30720.Cystatin C,47804,0.00458948377140553,0.00338164389700427,-0.00203853826672284,0.0112175058095339,0.174741448163856
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30730.Gamma glutamyltransferase,47787,0.00243700003053399,0.00336085551638242,-0.00415027678157555,0.00902427684264353,0.46839155185425
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30740.Glucose,46292,-0.00141651350601923,0.00283222989414599,-0.00696768409854537,0.00413465708650692,0.616982214405945
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47706,0.0134465110042995,0.00284446729937986,0.00787135509751499,0.019021666911084,2.29202357596524e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30760.HDL cholesterol,46303,0.0154827252496088,0.00334397506871332,0.00892853411493067,0.0220369163842869,3.68199445607315e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30770.IGF-1,47708,-0.0141276578169697,0.00297131602741379,-0.0199514372307007,-0.00830387840323863,2.00209532625562e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30780.LDL direct,47755,0.0111661982892692,0.00278999178606293,0.00569781438858589,0.0166345821899526,6.2983484484009e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30790.Lipoprotein A,43943,0.000286213258478205,0.00307729836473305,-0.00574529153639857,0.00631771805335498,0.925898447894135
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30810.Phosphate,46273,-0.000415399593478564,0.00288407398698724,-0.00606818460797355,0.00523738542101642,0.885476665298707
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30830.SHBG,46192,0.00775740918815095,0.00383765246033918,0.000235610365886148,0.0152792080104158,0.0432540665876325
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30840.Total bilirubin,47718,-0.00518611669402254,0.00304574635712932,-0.011155779553996,0.000783546165950924,0.088632834716665
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30850.Testosterone,47607,-0.000538079218411253,0.00476081198091579,-0.00986927070100619,0.00879311226418369,0.910013853042416
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30860.Total protein,46291,0.00266481480393361,0.00294377365566076,-0.00310498156116148,0.00843461116902871,0.365351817174304
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30870.Triglycerides,47777,0.00400481417360251,0.0029123594130766,-0.00170341027602764,0.00971303862323265,0.169113449098833
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30880.Urate,47771,0.00940806879337086,0.00351796773160403,0.00251285203942697,0.0163032855473148,0.00749509804524018
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30890.Vitamin D,47216,0.00311767690786022,0.00314488931957842,-0.00304630615851348,0.00928165997423393,0.321529006304478
CCND2,G1/S-specific cyclin-D2,Physical measures,X3137.Number of measurements made,46675,0.00940144998649655,0.0462121998158501,-0.0811744616525696,0.0999773616255627,0.838792750806291
CCND2,G1/S-specific cyclin-D2,Physical measures,X3143.Ankle spacing width,39925,0.00237307964942895,0.00516806087549634,-0.00775631966654388,0.0125024789654018,0.646112410661634
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39925,0.00271036313343535,0.00374882852907632,-0.00463734078355423,0.0100580670504249,0.469701352698194
CCND2,G1/S-specific cyclin-D2,Physical measures,X3146.Speed of sound through heel,39925,0.00258814082557131,0.00364013294316131,-0.00454651974302486,0.00972280139416747,0.477097805462418
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39925,0.00274070067451625,0.00366995147025907,-0.00445240420719151,0.00993380555622402,0.455202937936319
CCND2,G1/S-specific cyclin-D2,Physical measures,X3148.Heel bone mineral density (BMD),39906,0.00338720276463202,0.00369916162982549,-0.00386315402982593,0.01063755955909,0.359860748400479
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3526.Mother's age at death,40607,0.000348560117645602,0.00362538534554648,-0.00675719515962551,0.00745431539491671,0.923407576568181
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32304,0.00201304565053342,0.00653379945753669,-0.0107932012862385,0.0148192925873053,0.758025657226473
CCND2,G1/S-specific cyclin-D2,Physical measures,X4100.Ankle spacing width (left),35143,-0.0124839702550313,0.00651658373920361,-0.0252564743838704,0.000288533873807784,0.0554438809527853
CCND2,G1/S-specific cyclin-D2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35141,-0.00293212987260326,0.00472625890586481,-0.0121955973280983,0.00633133758289176,0.535021817177595
CCND2,G1/S-specific cyclin-D2,Physical measures,X4103.Speed of sound through heel (left),35143,0.00031134205769384,0.00453597346834205,-0.00857916594025658,0.00920185005564426,0.945279532630555
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35143,-0.000722098862082674,0.00459631280017351,-0.00973087195042275,0.0082866742262574,0.875167777892708
CCND2,G1/S-specific cyclin-D2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35137,7.06452515333227e-05,0.00460454400061405,-0.00895426098967022,0.00909555149273686,0.987759398480362
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35143,-0.000720557774814131,0.00459665348069102,-0.00972999859696854,0.00828888304734027,0.875441170975143
CCND2,G1/S-specific cyclin-D2,Physical measures,X4119.Ankle spacing width (right),35130,-0.00592507646006605,0.00640619023498894,-0.0184812093206444,0.00663105640051229,0.355052825547038
CCND2,G1/S-specific cyclin-D2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35129,-0.00300824034668356,0.0047408891551217,-0.0123003830907221,0.00628390239735496,0.525756683530637
CCND2,G1/S-specific cyclin-D2,Physical measures,X4122.Speed of sound through heel (right),35130,-0.001782674880711,0.00451008742817663,-0.0106224462399372,0.0070570964785152,0.692661027574629
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35130,-0.00172393840854241,0.00459084456282858,-0.0107219937516864,0.00727411693460161,0.707288489422882
CCND2,G1/S-specific cyclin-D2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35122,-0.00110338273021562,0.00460454094596894,-0.0101282829843147,0.0079215175238835,0.810625211176235
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35130,-0.00172643813403276,0.00459086740065684,-0.0107245382393202,0.00727166197125465,0.706885067661889
CCND2,G1/S-specific cyclin-D2,Physical measures,X4194.Pulse rate,35472,0.00268570112528573,0.00429604374897009,-0.00573454462269564,0.0111059468732671,0.531888884789397
CCND2,G1/S-specific cyclin-D2,Physical measures,X4195.Pulse wave reflection index,35472,-0.00152227594987257,0.00449248041488279,-0.0103275375630428,0.00728298566329771,0.734733259752269
CCND2,G1/S-specific cyclin-D2,Physical measures,X4196.Pulse wave peak to peak time,35464,-0.00298260706974398,0.00496100920042615,-0.0127061851025792,0.00674097096309127,0.54772014879127
CCND2,G1/S-specific cyclin-D2,Physical measures,X4198.Position of the pulse wave peak,35472,0.0149186414999989,0.00534806413031209,0.0044364358045872,0.0254008471954106,0.00529282540487882
CCND2,G1/S-specific cyclin-D2,Physical measures,X4199.Position of pulse wave notch,35472,0.00723317793288571,0.00432960976542118,-0.00125285720733981,0.0157192130731112,0.0948402305109627
CCND2,G1/S-specific cyclin-D2,Physical measures,X4200.Position of the shoulder on the pulse waveform,35472,0.0118368134174669,0.00545978783715741,0.00113562925663842,0.0225379975782955,0.0301929898872732
CCND2,G1/S-specific cyclin-D2,Physical measures,X4269.Number of triplets attempted (left),35270,-0.080461114461746,0.191958755511644,-0.456700275264568,0.295778046341076,0.675113938159502
CCND2,G1/S-specific cyclin-D2,Physical measures,X4270.Volume level set by participant (left),35195,-0.0307594796154139,0.0607769439187485,-0.149882289696161,0.0883633304653332,0.612800276032639
CCND2,G1/S-specific cyclin-D2,Physical measures,X4276.Number of triplets attempted (right),35274,0.0379053975247474,0.188474551406673,-0.331504723232331,0.407315518281826,0.840613391289579
CCND2,G1/S-specific cyclin-D2,Physical measures,X4277.Volume level set by participant (right),35199,-0.0997233441233031,0.0606921862615402,-0.218680029195922,0.0192333409493157,0.100409864220268
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4288.Time to answer,35441,-0.000722350251584325,0.00514846681279244,-0.0108133452046575,0.00936864470148886,0.888423970885615
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4290.Duration screen displayed,35441,-0.006915406365369,0.00474072543848001,-0.0162072282247898,0.00237641549405183,0.144687207277029
CCND2,G1/S-specific cyclin-D2,Physical measures,X46.Hand grip strength (left),48678,0.00739873552081132,0.0037083362203759,0.000130396528874558,0.0146670745127481,0.046038587120392
CCND2,G1/S-specific cyclin-D2,Physical measures,X47.Hand grip strength (right),48674,0.00511115435516398,0.00365557420248288,-0.00205377108170246,0.0122760797920304,0.162074171082314
CCND2,G1/S-specific cyclin-D2,Physical measures,X48.Waist circumference,48730,-0.016395415422997,0.00692832480922113,-0.0299749320490704,-0.00281589879692356,0.0179698441885452
CCND2,G1/S-specific cyclin-D2,Health and medical history,X4803.Tinnitus,35306,0.0703153969747937,0.0695815347970554,-0.0660644112274349,0.206695205177022,0.312269867925191
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4825.Noisy workplace,35378,-0.0341405454224548,0.0664215038522224,-0.164326692972811,0.0960456021279011,0.607269883939029
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4836.Loud music exposure frequency,35337,0.0129926323402916,0.0897516796511414,-0.162920659775946,0.188905924456529,0.884903120017077
CCND2,G1/S-specific cyclin-D2,Physical measures,X49.Hip circumference,48723,-0.00201090590044008,0.00508926269087089,-0.011985860774547,0.00796404897366686,0.692753235601722
CCND2,G1/S-specific cyclin-D2,Physical measures,X50.Standing height,48689,-0.00605118786780711,0.00385231709745615,-0.0136017293788212,0.00149935364320695,0.11624678086264
CCND2,G1/S-specific cyclin-D2,Health and medical history,X5057.Number of older siblings,34577,-0.0945143049630115,0.0658224471429976,-0.223526301363287,0.0344976914372638,0.151083774224878
CCND2,G1/S-specific cyclin-D2,Physical measures,X51.Seated height,48604,-0.0010363440212054,0.00336483777906137,-0.00763142606816568,0.00555873802575487,0.758091422020065
CCND2,G1/S-specific cyclin-D2,Eye measures,X5181.Ever had eye surgery,33237,-0.276221030651128,0.144566324188938,-0.559571026061446,0.00712896475918984,0.0561064200723081
CCND2,G1/S-specific cyclin-D2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33227,-0.0139168914875237,0.00553547576545419,-0.024766423987814,-0.00306735898723353,0.0119663983853713
CCND2,G1/S-specific cyclin-D2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33224,-0.00962742061353765,0.00569630599293597,-0.0207921803596922,0.00153733913261685,0.0910730775507212
CCND2,G1/S-specific cyclin-D2,Eye measures,X5190.Duration at which refractometer first shown (right),33179,-0.0073208168463732,0.0057126919051997,-0.0185176929805646,0.0038760592878182,0.200082855030063
CCND2,G1/S-specific cyclin-D2,Eye measures,X5193.Duration at which refractometer first shown (left),33176,-0.00640353482215251,0.00576649146578688,-0.0177058580950948,0.00489878845078978,0.26685347343497
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5199.logMAR, initial (right)",33206,-0.0434401664970662,0.0763181075543544,-0.193023657303601,0.106143324309468,0.56924907330302
CCND2,G1/S-specific cyclin-D2,Eye measures,X5200.Final number of letters displayed (right),33206,0.195631499353523,0.44608203833964,-0.678689295792171,1.06995229449922,0.661004601377145
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5201.logMAR, final (right)",33153,-0.000300051178621424,0.00547925046631393,-0.0110393820925967,0.0104392797353539,0.956330991279555
CCND2,G1/S-specific cyclin-D2,Eye measures,X5202.Number of rounds to result (right),33206,-0.0678111707641351,0.0723150692046629,-0.209548706405274,0.0739263648770041,0.348438430669717
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5206.logMAR, initial (left)",33202,-0.0417609032765798,0.0763628606626778,-0.191432110175428,0.107910303622269,0.58449145851155
CCND2,G1/S-specific cyclin-D2,Eye measures,X5207.Final number of letters displayed (left),33202,-0.00176010280781328,0.47706969743998,-0.936816709790173,0.933296504174547,0.997056448240007
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5208.logMAR, final (left)",33165,-0.00378945414584136,0.00557207137600863,-0.0147107140428183,0.00713180575113556,0.496488311474078
CCND2,G1/S-specific cyclin-D2,Eye measures,X5209.Number of rounds to result (left),33198,-0.0512191190471282,0.072212467542783,-0.192755555430983,0.0903173173367265,0.478184551614678
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33033,0.0102715923814717,0.00550516517925184,-0.000518531369861878,0.0210617161328054,0.0621339463348538
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33033,0.0157671334679196,0.00540910347343752,0.00516529065998206,0.0263689762758571,0.00357555407555134
CCND2,G1/S-specific cyclin-D2,Eye measures,X5256.Corneal hysteresis (right),33033,0.00470922618875673,0.00561842063977542,-0.00630287826520309,0.0157213306427165,0.40197696866901
CCND2,G1/S-specific cyclin-D2,Eye measures,X5257.Corneal resistance factor (right),33033,0.0120485158316361,0.00553692300984874,0.00119614673233256,0.0229008849309396,0.0296055807506083
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33010,0.0144328023027832,0.00553291181733661,0.00358829514080343,0.0252773094647629,0.0091237163881586
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33010,0.0141538190367483,0.0054817172476453,0.00340965323136353,0.0248979848421331,0.00985479010647805
CCND2,G1/S-specific cyclin-D2,Eye measures,X5264.Corneal hysteresis (left),33010,-0.00576540153743346,0.00554810804212523,-0.0166396932999989,0.00510889022513199,0.298784820587136
CCND2,G1/S-specific cyclin-D2,Eye measures,X5265.Corneal resistance factor (left),33010,0.00219492902215983,0.0055189957983752,-0.00862230274265556,0.0130121607869752,0.69086732829543
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33781,0.567154284867795,0.37076285453037,-0.159540910011731,1.29384947974732,0.126153169303327
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48682,-0.00486137413171444,0.0151138401286315,-0.0344845007838321,0.0247617525204032,0.74772083453653
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48682,-0.0260561185988963,0.0172809561368697,-0.0599267926271609,0.00781455542936829,0.131623038860187
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48682,-0.0373000230076658,0.043461621928393,-0.122484801987316,0.0478847559719845,0.390776285195243
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48682,-0.0117686936054837,0.00685123294734656,-0.0251971101822829,0.0016597229713156,0.0858579551705507
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48682,0.0139776977225438,0.00635718094138501,0.00151762307742915,0.0264377723676584,0.027908788455812
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37418,-0.0198601342830263,0.00806370531131842,-0.0356649966932104,-0.00405527187284221,0.0138006394052724
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37418,-0.0535612512470077,0.0245441461465311,-0.101667777694209,-0.00545472479980676,0.0291180230925539
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37418,-0.00799969158804146,0.0155504553203529,-0.0384785840159331,0.0224792008398502,0.606961096555276
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37418,0.0245485974987035,0.00938193226596451,0.00616001025741303,0.0429371847399939,0.00889664499183638
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48744,0.00644131259951949,0.014399349558245,-0.0217814125346406,0.0346640377336796,0.654639034069934
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48744,0.00644131259951949,0.014399349558245,-0.0217814125346406,0.0346640377336796,0.654639034069934
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48744,-0.0110549678732484,0.0105222080325815,-0.0316784956171081,0.00956855987061124,0.29344026783221
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48744,-0.00932145040962673,0.0185331809972342,-0.0456464851642057,0.0270035843449523,0.614997829880912
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48744,0.0276031531040893,0.0435159137345051,-0.0576880378155406,0.112894344023719,0.525877130334391
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48744,0.00630119073547221,0.0306553463824518,-0.0537832881741333,0.0663856696450777,0.837144915087655
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48744,-0.0118159494167463,0.0470221358042499,-0.103979335593076,0.0803474367595836,0.801596465804157
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48681,-0.0168026720659218,0.00939009550649031,-0.0352072592586428,0.00160191512679918,0.0735648812897429
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48681,-0.0116062140591019,0.0163856686488543,-0.0437221246108564,0.0205096964926526,0.478757917209081
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48681,-0.0174179217467658,0.00853201255384229,-0.0341406663522967,-0.000695177141234911,0.0412163129439746
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48681,0.00741346193104253,0.0126138553708333,-0.0173096945957908,0.0321366184578758,0.55672436408239
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48681,-0.0154059382600796,0.0127041635077191,-0.040306098735209,0.00949422221504986,0.225270873070294
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48681,-0.00609994223270788,0.00723137021968079,-0.0202734278632822,0.00807354339786646,0.39893715563489
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35799,0.00499575290258692,0.0135485279267258,-0.0215593618337957,0.0315508676389696,0.712339597114745
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35799,0.00377131631147354,0.0128853768998801,-0.0214840224122915,0.0290266550352385,0.769773757864821
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35799,-0.00602000419245588,0.0186971108888314,-0.0426663415345653,0.0306263331496536,0.747480905057742
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35799,0.00301369444595265,0.0138380247308352,-0.0241088340264843,0.0301362229183896,0.827603917880671
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48640,-0.0167899332377923,0.0253137325738555,-0.0664048490825491,0.0328249826069645,0.507162902254189
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48640,0.015458495070926,0.0313384167429237,-0.0459648017452045,0.0768817918870565,0.62182284912017
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48640,-0.0608344756357205,0.0593962410326875,-0.177251108059788,0.0555821567883469,0.305746459025086
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48640,-0.0323754824948744,0.0573100713121906,-0.144703222266768,0.0799522572770193,0.572135962690246
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48640,-0.0269496446950843,0.0237114089292536,-0.0734240061964213,0.0195247168062527,0.255732230828484
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48640,-0.0520388691280261,0.0276882592705942,-0.106307857298391,0.0022301190423386,0.0601967335812773
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48640,0.0127677231806534,0.0118179236385233,-0.0103954071508524,0.0359308535121591,0.279990713947836
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34633,0.0101303558711641,0.0200478544020567,-0.029163438756867,0.0494241504991952,0.613360470230869
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34633,0.0127313524221504,0.0194335111211074,-0.02535832937522,0.0508210342195209,0.512413134354199
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34633,0.0289365605284918,0.028244463385126,-0.0264225877063552,0.0842957087633388,0.305638445683722
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34633,0.00460156086523277,0.0100875912317337,-0.0151701179489653,0.0243732396794308,0.648290972505243
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37304,0.002507906159076,0.0087049128150747,-0.0145537229584704,0.0195695352766224,0.773275225367741
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37304,-0.00594074965244901,0.00957918935838641,-0.0247159607948864,0.0128344614899883,0.53516047141444
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37304,-0.00200794953320587,0.00850542168285518,-0.018678576031602,0.0146626769651903,0.813377098183577
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37305,-0.0113355253713441,0.0198589129023376,-0.0502589946599259,0.0275879439172377,0.568147980881303
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37305,0.00553400696702637,0.0118159147399414,-0.0176251859232588,0.0286931998573115,0.639544634621457
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37305,-0.0268848445810724,0.0215603651043879,-0.0691431601856727,0.015373471023528,0.212446875234665
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48681,0.0224106376919016,0.0185467934269873,-0.0139410774249935,0.0587623528087966,0.226934773237765
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48681,0.015567736721087,0.0148819298397032,-0.0136008457647313,0.0447363192069052,0.295535214374384
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48681,-0.00786129753697541,0.0308812593969496,-0.0683885659549965,0.0526659708810457,0.799061457768788
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48681,0.0160983178663592,0.0166621974960448,-0.0165595892258885,0.048756224958607,0.333976687011705
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48681,0.0257827403748572,0.0170950783786826,-0.00772361324736081,0.0592890939970752,0.131519929776262
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48681,0.0214639521545753,0.0206981173694012,-0.0191043578894512,0.0620322621986017,0.299748243894925
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48681,-0.0113529221206245,0.00600615296979439,-0.0231249819414215,0.00041913770017251,0.0587435603762358
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33381,0.00230943411365308,0.0150209060409298,-0.0271315417265694,0.0317504099538756,0.877814932888863
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33381,-0.00721144068952619,0.0181218136671767,-0.0427301954771925,0.0283073140981401,0.690690303788651
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33381,-0.00224212695602953,0.0134817274186504,-0.0286663126965844,0.0241820587845253,0.867921145909516
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33381,-0.00650240569188609,0.0120654868585787,-0.0301507599347004,0.0171459485509282,0.589962944659428
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48770,0.00057101495830726,0.00728595043310638,-0.0137094478905812,0.0148514778071958,0.937532873961675
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48770,-0.00105797966026172,0.023913647311927,-0.0479287283916386,0.0458127690711152,0.964712205736832
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48770,-0.00778551080986996,0.00642281691118151,-0.0203742319557857,0.00480321033604579,0.225463606742726
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48770,-0.00217693670107278,0.00600708155244415,-0.0139508165438633,0.00959694314171775,0.717060624731151
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48770,-0.00148614482397734,0.0102732853075713,-0.021621784026817,0.0186494943788623,0.884979893626908
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48770,-0.0136203205385091,0.0091410619788298,-0.0315368020170155,0.00429616093999727,0.136235897455585
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48770,-0.00372688704567598,0.00649192999264895,-0.0164510698312679,0.00899729573991597,0.565920081211921
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48770,0.00581566762918492,0.0211758459740257,-0.0356889904799055,0.0473203257382754,0.78359806527163
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42628,-0.012639869906073,0.00669845580008291,-0.0257688432742355,0.000489103462089479,0.0591832884784303
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42628,0.0100385031079666,0.00660186444077891,-0.00290115119596004,0.0229781574118933,0.128393890034411
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42628,0.0190599249492491,0.00851417284540163,0.00237214617226188,0.0357477037262363,0.0251968270816553
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42629,-0.00596857030633713,0.0132397703526547,-0.0319185201975403,0.019981379584866,0.652136213455359
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42629,-0.0117769578709568,0.00754786562355995,-0.0265707744931343,0.00301685875122073,0.118710835802068
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48582,-0.0108239709183453,0.00689698500633759,-0.024342061530767,0.00269411969407632,0.116575910761901
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48582,0.00772543893750931,0.00541932232057723,-0.00289643281082206,0.0183473106858407,0.154017948455888
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48582,0.0026178910632064,0.00612345728057306,-0.0093840852067168,0.0146198673331296,0.669006344968668
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48582,0.0182796785994836,0.00936187664221929,-6.95996192661939e-05,0.0366289568182334,0.0508850294675653
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48600,-0.00734905176549621,0.0058241352383897,-0.01876435683274,0.0040662533017476,0.207025718337444
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48600,-0.0100406493284602,0.00814076094623241,-0.0259965407830758,0.0059152421261553,0.21744862865172
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48681,0.00506922889231025,0.00596298356598688,-0.00661821889702405,0.0167566766816445,0.395270624749005
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48681,0.00411164791296891,0.00749276195329555,-0.0105741655154904,0.0187974613414282,0.583183605854033
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48681,-0.0338690013946202,0.0157943603238605,-0.0648259476293868,-0.00291205515985356,0.0320149701618791
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48681,0.00326096582906724,0.0147612415535185,-0.0256710676158291,0.0321929992739636,0.825161594169844
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48681,-0.0308781059442357,0.017798590341662,-0.0657633430138931,0.00400713112542177,0.0827805158669641
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48681,0.0406301464364476,0.0180741667685831,0.00520477957002476,0.0760555133028704,0.0245890418579853
CCND2,G1/S-specific cyclin-D2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39925,0.0027402348430714,0.00366996656987643,-0.0044528996338864,0.0099333693200292,0.455281424382307
CCND2,G1/S-specific cyclin-D2,Physical activities,X864.Number of days or week walked 10+ minutes,48373,-0.00732869455577753,0.0346195996483372,-0.0751831098665184,0.0605257207549633,0.832349461118886
CCND2,G1/S-specific cyclin-D2,Physical activities,X874.Duration of walks,46104,0.00562844461940527,0.00279935737594247,0.000141704162558018,0.0111151850762525,0.0443808911432551
CCND2,G1/S-specific cyclin-D2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47845,0.110490831056313,0.0331384414894745,0.0455394857369434,0.175442176375683,0.00085700739041415
CCND2,G1/S-specific cyclin-D2,Physical activities,X894.Duration of moderate activity,43759,0.0717235490343209,0.0397133454890136,-0.00611460812414573,0.149561706192788,0.0709332624537269
CCND2,G1/S-specific cyclin-D2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32540,0.00738601600331408,0.00637467942455045,-0.0051083556688048,0.019880387675433,0.246669503988919
CCND2,G1/S-specific cyclin-D2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47782,0.0425772187659429,0.0341301605933961,-0.0243178959971134,0.109472333528999,0.212231135635954
CCND2,G1/S-specific cyclin-D2,Physical activities,X914.Duration of vigorous activity,40078,-0.000181303112158441,0.00334803149197604,-0.00674344483643148,0.0063808386121146,0.956814883881797
